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THE EFFECTS OF CHILDHOOD IRRITABILITY ON ADOLESCENT OUTCOMES 




Advisor: Dr. Jeffrey M. Halperin 
Childhood irritability has received considerable attention in recent research due in part to the highly 
impairing consequences of severe irritability and its association with poor long-term outcomes 
(Leibenluft, Cohen, Gorrindo, Brook, & Pine, 2006; Stringaris, Cohen, Pine, & Leibenluft, 2009; 
Stringaris & Goodman, 2009a). While the frequency and severity of irritability typically declines with 
age, there are individuals who continue to display irritability at stable or increasing levels (Wiggins, 
Mitchell, Stringaris, & Leibenluft, 2014). Regardless of whether it persists or remits, the effects of 
childhood irritability resonate for many years and it remains a potent predictor of poor outcomes across 
the lifespan. The presence of childhood irritability is central to a diagnosis of ODD which is made up of 
3-highly-intercorrelated dimensions in the DSM-5: irritability, defiance, and vindictiveness. ODD is 
highly comorbid with Attention-deficit/Hyperactivity Disorder (ADHD), which has been shown to 
exacerbate impairments in interpersonal and psychosocial functioning compared to impairments related to 
irritability alone (Wehmeier, Schacht, & Barkley, 2010). To date, research has examined associations 
between irritability in adolescence and subsequent adult outcomes; however, less is known about the 
stability of irritability from childhood through adolescence, particularly in individuals with ADHD, and 
which factors may moderate stability and outcomes. Neurodevelopmental models postulate that emotion 




psychopharmacological treatments for ADHD have been shown to result in improvements in both of these 
areas, little is known about the mechanisms that bring about these improvements. This dissertation 
examined 1) the developmental stability of irritability and defiance, and the degree to which the presence 
and variability of these symptom dimensions predict adolescent outcomes, and 2) factors associated with 
changes in emotional control following psychopharmacological treatment in children with ADHD. 
Results revealed that irritability and defiance are moderately stable from childhood through adolescence 
in children with ADHD. The stability of irritability was moderated by socioeconomic (SES) status such 
that it is quite stable over time in youth from higher SES, but far less stable in those from more 
disadvantaged backgrounds. Neither childhood irritability nor defiance predicted later internalizing 
problems, but both predicted later externalizing problems (e.g., anger, aggression), as well as cigarette 
use. Therefore, irritability and defiance are maladaptive in an ADHD population and may increase the 
risk for negative long term outcomes. Treatment with atomoxetine and methylphenidate demonstrated 
comparable improvements in emotional control, showing shared as well as distinct effects on different 
aspects of cognitive control. Pre-treatment cognitive control and improved cognitive control following 
treatment were associated with greater improvements in emotional control. Interventions that target 
cognitive control may serve as an effective adjunctive treatment for individuals with ADHD and emotion 
dysregulation. 
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Irritability has received considerable attention in recent research due in part to its 
association with poor long-term outcomes (Stringaris, Cohen, Pine, & Leibenluft, 2009; 
Stringaris & Goodman, 2009a; Leibenluft, Cohen, Gorrindo, Brook, & Pine, 2006). Irritability is 
a dimensional trait that is present at elevated levels in many typically developing individuals, and 
it is also a feature of a range of psychiatric diagnoses. It is characterized by a tendency to be 
easily annoyed, to be unable to control one’s anger, to have a low threshold for frustration, and 
by a readiness to explode in response to slight provocations (Buss & Durkee, 1957; Caprara, 
Cinanni, D’ Imperio, Passerini, Renzi, & Travaglia, 1985; Kazdin, 1987; Snaith & Taylor, 1985). 
In childhood, irritability typically manifests as being easily annoyed and having temper outbursts 
(Baum & Kowatch, 2014). In adolescence, irritability typically manifests as reactive aggression 
including angry facial expressions, verbalizations, temper tantrums, or hostility towards adults 
and others (Price & Dodge, 1989). Population-based studies suggest that severe irritability ranges 
in prevalence from 3% (Althoff, Verhulst, Rettew, Hudziak, & van der Ende, 2010; Brotman et 
al., 2006) to 20% (Pickles et al., 2010), with an overwhelming number of referrals to child and 
adolescent clinics related to rage and severe temper outbursts at home or in school (Bufferd, 
Dougherty, Carlson, & Klein, 2011; Lavigne, Lebailly, Hopkins, Gouze, & Binns, 2009). The 
presence of irritability alone does not indicate a clinically diagnosable disorder or a vulnerability 
to the later emergence of psychiatric illness. Thus, it is critical that the frequency, persistence, 





Irritability is a critical characteristic of several disorders across the lifespan in the DSM, 
including disruptive, impulse-control, and conduct disorders in childhood, and mood, anxiety, 
and personality disorders (APA DSM-5, 2014). More specifically, irritability is a criterion for 
disorders of children as young as three years-old, including ODD and Intermittent Explosive 
Disorder (IED). Irritability is also a criterion for childhood mood disorders such as (DMDD), a 
new DSM-5 diagnosis, as well as part of adolescent and adult mood disorders including 
persistent depressive disorder and dysthymia. Lastly, irritability is a symptom of anxiety 
disorders including generalized anxiety disorder and post-traumatic stress disorder (PTSD), and 
personality disorders including borderline and antisocial personality disorders. Thus, irritability 
appears to be a dimension that cuts across a variety of disorder categories. An important question 
is whether varying levels of irritability are predictive of later psychopathology.  
The essential features of irritability are the quickness and ease by which anger is induced 
and an intense reaction that is disproportionate to the inducing situation, often marked by 
aggression and hostility. Few scales capture the wider phenomenology of irritability precisely, 
with most highlighting its behavioral components (e.g., tantrums, hostility), and rarely 
addressing its emotional components (e.g., negative affect, heightened physiological arousal, 
low-frustration threshold). A simplified yet comprehensive definition for irritability is as follows: 
a state of affective inclination to episodes of temper outbursts and anger in response to minimal 
provocation and experienced frustration.  
It is clear that while irritability is a common feature of day-to-day life, there are 




Understanding the developmental processes underlying typical and atypical irritability is key to 
understanding its role in overall mental health.  
Developmental course of irritability 
Negative temperament emerges as early as infancy, with terms such as “difficult” used to 
describe infants with a general negative affect (e.g., fussy, angry, difficult to control) who 
express irritable behavior to a more frequent and more severe extent than their typically 
developing peers (Egger & Angold, 2006; Goldsmith, Lemery, & Essex, 2004; Olson, Bates, 
Sandy, & Schilling, 2002). In typical development, daily temper tantrums and emotional 
outbursts occur frequently (i.e., multiple times a day) in toddlerhood and tend to peak at age 4 
(Frick et al., 1993), decreasing in frequency as the child matures. Declines in aggression and 
emotional outbursts have been attributed to the child’s development of language and self-
regulatory abilities. With increased language, the child will rely on more verbal rather than 
physical expressions of their needs. With an increased ability to regulate their emotions and 
behavior (e.g., inhibitory control), the child’s tolerance for frustration will also increase 
(Vallotton & Ayoub, 2012). However, while the majority of children that exhibit irritability early 
on will experience a gradual decline in emotional outbursts and aggression with age, this is not 
the case for a subset of children for whom irritability can persist through childhood, adolescence, 
and for some, even into adulthood (Moffit, Caspi, Dickson, Silva, & Stanton, 1996; Shaw, 
Gilliom, Ingoldsby, & Nagin., 2003). The variability in trajectories of early irritability indicates 






Stability of Irritability 
Identifying developmental pathways of early irritability may be crucial to understanding 
the development of subsequent psychiatric, behavioral, and personality disorders for which 
irritability is a criterion. Findings from a handful of longitudinal studies starting in adolescence 
support the notion that irritability is highly stable (Caprara, Paciello, Gerbino, & Cugini, 2007; 
Frick et al., 1993; Leadbeater & Homel, 2015). Several studies found that individuals with 
initially high or initially low levels of irritability tended to maintain the same levels across a 
period of six to eight years from adolescence into adulthood (Caprara et al., 2007; Leadbeater & 
Homel, 2015). Caprara and colleagues further identified four distinct trajectories for irritability 
measured from adolescence to adulthood: low stable, medium declining, medium stable and high 
stable (Caprara et al., 2007). A longitudinal study comparing dimensions of ODD over time from 
adolescence through young adulthood (ages 18-25 years old) found that while irritability was 
highly stable, defiance declined in a linear fashion (Leadbeater & Homel, 2015).  
Leibenluft and colleagues (2006) further explored the degree to which different levels or 
patterns of irritability, either chronic (characteristic of the child most of the time) or episodic, 
have distinct trajectories. Whereas chronic irritability was found to increase with age, peak in 
mid-adolescence, and subsequently decline, episodic irritability was found to increase linearly 
through adolescence.  
Most studies examining the stability of irritability support the notion that it is highly 
stable between adolescence (12-13 years old) and early adulthood (18-22 years old; Caprara et 
al., 2007; Leibenluft et al., 2006; Leadbeater & Homel, 2015). However, irritability in childhood 




childhood, from ages one through nine years old (Wiggins, Mitchell, Stringaris, & Leibenluft, 
2014), found 5 distinct trajectories of stability, with four of them indicating a change from 
baseline (Low decreasing, moderate decreasing, high increasing, high then low, and high steady). 
While further studies are needed, current research indicates that rates of irritability fluctuate 
considerably in childhood, and then tend to remain stable throughout adolescence and adulthood. 
These findings make sense in light of other research which indicates that irritable behaviors (i.e., 
loses temper, defies, argues, irritable, angry) emerge earlier than and precede the onset of other 
disruptive behaviors (i.e., spiteful, bullies, cruel, lies, steals, vandalizes, truant, swears; Frick et 
al., 1993). Therefore, given the range of fluctuations that are present during this developmental 
period, measuring irritability in childhood may be key to understanding individual differences in 
persisters and remitters, and their associations with poor outcomes. Additionally, the 
measurement of behaviors closely related to childhood irritability, such as defiance and 
vindictiveness, will provide further specificity of the stability and differential outcomes of 
irritability. 
Outcomes associated with irritability from childhood through adulthood 
While the frequency and severity of irritability in typical development generally declines 
with age, its effects resonate for many years and it remains a potent predictor of poor outcomes 
across the lifespan. The presence of irritability at 3 years-old has been found to predict 
depression, ODD, and poor relationships with parents, siblings and peers, as well as difficulties 
in academic and recreational contexts, by the age of 6 (Dougherty, Tolep, Smith, & Rose, 2013). 
Other studies have found that by the age of 10, and likely much earlier, children with a history of 




1996). Price and Dodge (1989) have long maintained that irritable behavior elicits negative 
social interactions, increasing the risk of experiencing social and emotional difficulties including 
but not limited to poor social skills, antagonistic relationships (e.g., family members, peers, and 
other adult figures; Price & Dodge, 1989), and at greater extremes, aggression and behavioral 
disorders (i.e., ODD, ADHD, CD). 
High levels and high stability of irritability in middle childhood (7-12 years old) have 
been shown to significantly increase the risk of developing mood, anxiety, and behavioral 
disorders by age 13, and as far as age 18 (Boylan, Vallaincourt, & Szatmari, 2012; Burke, 2012; 
Frick et al., 1993; Nagin & Tremblay, 1999). The close relationship between irritability and 
depression is further substantiated by findings that depressive symptoms in adolescence had 
preceding or co-occurring moderate to high-level symptoms of irritability in childhood (Frick et 
al., 1993). Research also provides evidence for the idea that childhood irritability is associated 
with the early onset and persistence of major depression (Fava et al., 2010), anxiety, suicidality, 
and antisocial behavior in adolescence and young adulthood (Leibenluft & Stoddard, 2013). 
Findings from longitudinal studies indicate an association between the ODD irritable dimension 
and the development of mood and anxiety disorders (Burke et al., 2010; Leadbeater & Homel, 
2015; Stringaris & Goodman, 2009a; Whelan et al., 2013). These outcomes contrast those 
associated with the other highly intercorrelated ODD dimensions of defiance and vindictiveness. 
Specifically, defiance/headstrongness was associated with the development of CD and ADHD 
(Leadbeater & Homel, 2015; Stringaris & Goodman, 2009a), delinquency and callousness 
(Whelan et al., 2013), and substance use disorders (Rowe et al., 2010). The hurtful/vindictive 
dimension was associated with the development of CD and antisocial personality disorder 




Irritability in middle childhood and adolescence was also found to predict poor functional 
outcomes in adulthood including low income and lower educational attainment, as well as poor 
quality of romantic relationships (Stringaris et al., 2009). A longitudinal community-based study 
found that adolescent irritability increased risk for generalized anxiety and depression in 
adulthood, and was strongly associated with high physical aggression, verbal aggression, and 
violent episodes eight years later (i.e., fighting, vandalism, and use of weapons; Caprara et al., 
2007). Another community-based longitudinal study found that youth irritability continued to be 
a significant predictor of adult psychiatric outcomes 20-years later (Stringaris et al., 2009). More 
specifically, chronic irritability in adolescence predicted psychiatric disorders in adolescence and 
adulthood, namely simple phobias and mania at age 16, and depression and anxiety at age 33 
(Leibenluft & Stoddard, 2013). An additional longitudinal, community-based study found that 
chronic irritability at ages 14-15 years old was a significant risk for adult suicidality 30 years 
later, demonstrating an association with mood as well as additional effects beyond disorders in 
adulthood (Pickles et al., 2010). Findings of poor psychosocial, psychiatric, and socioeconomic 
outcomes have been replicated and extended in a handful of community-based samples.  
Most research measuring the development of irritability to date has focused on 
community-based samples which tend to have lower levels of symptomatology relative to 
clinical samples, thus contributing to weaker associations between the presence of irritability and 
outcomes (Caprara et al., 2007; Leibenluft et al., 2006). Furthermore, the pervasiveness, 
heterogeneity of presentations, as well as the range of outcomes associated with irritability are 
likely indicative of subtypes within a broader clinical phenotype, thus necessitating research on 
irritability to be rooted in its dimensionality, a technique supported by contemporary 




need for more research on varying levels of irritability utilizing clinic-referred samples to 
examine stability and outcomes over development.  
Factors that contribute to Irritability  
Although previous research demonstrates the stability and poor outcomes associated with 
the presence of irritability, it does not elucidate factors that contribute to its emergence and the 
distinct trajectories. Nevertheless, considerable literature links irritability to temperament 
(Boylan et al., 2012; Drabick, Ollendick, & Bubier, 2010; Stringaris, Maughan, & Goodman, 
2010) and the biological roots of anger regulation (Bidwell, Dew, & Kollins, 2010), as well as 
environmental factors (Wiggins et al., 2014). A four-factor model proposed by Barkley (2013) 
delineates the mutual and reciprocal pathways by which negative temperament, defiance, social 
aggression, parental psychopathology, disrupted parenting, and family stressors influence and 
contribute to the development and persistence of a child’s behavior, which may be useful in 
understanding the development and persistence of irritability. 
Temperament 
 Temperament is defined as a behavioral tendency present early in life that is relatively 
stable across contexts and time. Temperament is commonly used to describe an individual’s 
ability to regulate their emotions, activity, and attention (Caspi & Shiner, 2008). Although 
temperament is generally considered to be innate, emerge in infancy, and show developmental 
stability, it is subject to change in response to experience (Caspi & Shiner, 2008; Nigg, 2006). 
Developmental psychology has long acknowledged the relationship between temperament and 
psychopathology, and it is often explained through two theoretical models: the vulnerability 




temporally delayed development of psychopathology (Zubin & Spring, 1977), such that the 
presence of early irritability increases one’s vulnerability to the subsequent development of 
psychopathology. The dimensional-spectrum model postulates that extreme or atypical levels of 
a trait will result in psychopathology, and that specific patterns of disorders across time 
“delineate continuous underlying propensities to experience psychopathology” (Krueger & 
Markon, 2006). Findings of irritability and defiance being associated with propensities towards 
internalizing and externalizing disorders later in life may be the key to understanding how 
irritability exerts its effects on a range of outcomes over time. 
Temperamental factors of emotionality and activity early on in development have been 
implicated as contributing to the risk of developing ODD, as well as underlying its wide range of 
associations with other disorders (Boylan et al., 2012; Drabick et al., 2010; Stringaris et al., 
2010). More specifically, Stringaris and colleagues (2010) found that Emotionality (cries easily, 
fussy, intense reaction when upset) at 3-years old was a predictor of comorbidity with 
internalizing disorders, and Activity (always on the go, energetic, active as soon as wakes up) 
was a predictor for comorbidity with additional externalizing disorders. These findings are in line with 
findings of others showing that parent-ratings of emotionality and activity on the Child Behavior 
Questionnaire (CBQ) are strong predictors of oppositional symptoms (De Pauw, Mervielde, & 
Van Leeuwen, 2009). Stringaris and colleagues (2010) conclude that temperamental emotionality 
represents a shared risk factor for oppositional and emotional problems. Similarly, 
temperamental activity represents a shared risk factor between oppositional and other behavioral 
problems including the Hyperactive and Combined presentations of ADHD, but not the 
inattentive presentation. It is possible that early temperamental precursors that contribute to 




There is also evidence to suggest that the effects of early childhood temperament may be 
different across genders. Whereas negative temperament in young boys is predictive of later 
oppositional behavior, negative temperament in young girls likely increases risk for internalizing 
disorders (Keenan & Shaw, 1994). 
Emotional Regulation, ADHD, and special ties to irritability 
Emotion regulation is defined as an individual’s ability to manage their emotions in a 
flexible and goal directed way which allows them to exhibit socially appropriate behaviors 
(Campos, Campos, and Barrett, 1989). Research demonstrates that emotion regulation difficulty, 
particularly with a tendency towards negative affect including anger and frustration, is a 
diagnostically significant and strong predictor of behavior problems and future psychopathology 
(McLaughlin, Hatzenbeuhler, Mennin, & Nolen-Hoeksema, 2011; Rothbart, 2007). Several 
studies support the idea that children with ODD have difficulty with emotion regulation (Burke, 
Loeber, & Birmaher, 2002; Eisenberg et al., 2001), and deficits in these abilities are reflected in 
symptoms such as being easily annoyed and experiencing frequent and severe temper outbursts. 
Further, increased emotion regulation is associated with decreased oppositional behaviors 
(Eisenberg et al., 2001). It is likely that symptoms comprising the ODD-irritable dimension (i.e., 
temper outbursts, anger, and touchiness) arise from both early negative temperament and early 
emotion dysregulation.  
ODD shares the dimension of heightened emotionality with another closely associated 
and highly comorbid disorder, ADHD (Singh & Waldman, 2010). ADHD has long been 
considered a neurodevelopmental disorder that results from deficits in behavioral and emotional 




two symptom criteria for ADHD (along with inattention), and emotion dysregulation is 
considered an associated feature of ADHD in the DSM-IV and 5 (Clements, 1996; Shaw, 
Stringaris, Nigg, & Leibenluft, 2014). Externalizing symptoms that accompany ADHD, 
including impulsivity and difficulty inhibiting responses, contribute to low frustration tolerance 
that result in irritability, anger, and dysregulated emotional behavior (Melnick & Hinshaw, 
2000). Moreover, core ADHD symptoms, particularly hyperactive-impulsive symptoms, have 
been shown to have a significant positive association with increasing severity of emotional 
lability (Sobanski et al., 2010). It is clear that emotion dysregulation plays a major role in both 
ODD and ADHD.  
While many individuals with ADHD do not have emotional difficulties, the high 
prevalence of emotional lability in individuals with ADHD warrants further attention. Overall, 
findings demonstrate that emotion dysregulation occurs in 25-50% of children with ADHD and 
30-70% of adults with ADHD (Sobanski et al., 2010; Shaw et al., 2014). Symptoms of emotional 
lability (i.e., frequent, rapid, unpredictable, and marked changes in mood) were ten times more 
prevalent in a sample of youth with ADHD as compared to the general population (Stringaris & 
Goodman, 2009b). Irritability was present in as many as 76.1% of individuals with ADHD 
without mood disorders (Geller et al., 2002).  
 Importantly, the presence of irritable symptoms in children with ADHD has been shown 
to increase risk for comorbid diagnoses (Ambrosini et al., 2013). Researchers compared children 
who presented with ADHD and irritability or emotion dysregulation to non-irritable children 
with ADHD, and found that the former group, which made-up 21% of the sample, had higher 




majority had comorbid ODD or a co-occurring mood disorder (83.8% and 76.2%, and 
respectively), and the remaining presented with clinically elevated levels of ODD symptoms and 
anxiety disorders (Ambrosini et al., 2013). While these findings are intriguing, limitations in 
methods, including that this was a cross-sectional sample of Caucasian children with a mean age 
of 10, limit the extent to which findings could be generalized to other ages and populations, and 
the determination of extent to which early irritability is associated with long-term psychiatric 
outcomes. A separate study found that ADHD combined with emotion dysregulation is 
associated with significantly greater impairments in peer relationships, family, academic 
performance, and occupational attainment (Wehmeier, Schacht, & Barkley, 2010).  
It is still unclear how irritability influences the presentation of ADHD, and how the onset 
and the severity of irritability in early childhood influence subsequent development and 
outcomes. Future research examining correlates of ADHD and ODD symptom dimensions 
should measure dimensions longitudinally to allow for the evaluation of developmental patterns, 
especially given the range of outcomes. 
Environment 
Environmental factors play etiological roles in the development of disruptive behaviors in 
children (Frick et al., 1993). It has long been acknowledged that socioeconomic status (SES) and 
factors that contribute to SES (i.e., parental education, employment status, and marital status) 
influence child development. In fact, children with difficult temperament most often come from 
families with low-SES (Wasserman et al., 1990 as cited in Walsh, 2014). Research demonstrates 
that parental unemployment and single-parenthood are associated with higher risk for the 




the CBCL, and more specifically with risk for internalizing symptoms on the CBCL (Harland et 
al., 2002). Other research examining the links between family factors and children’s disruptive 
behavior shows that children of mothers with lower levels of education (≤ 9 years) had more 
symptoms of ODD and ADHD than children of mothers with higher levels (>9 years; Rydell, 
2010). Literature on the developmental trajectories of childhood irritability show that children 
with more severe levels of irritability (i.e., high increasing, high then low, and high steady) were 
more likely to live in single-mother homes, to have mothers with lower educational attainment, 
to live in worse neighborhoods, to have mothers that were victims of or witnessed violence, and 
to experience more and harsher parental discipline (Wiggins et al., 2014).  
Environmental factors including childhood maltreatment (i.e., Emotional Abuse, Physical 
Abuse, Sexual Abuse, Emotional Neglect, and Physical Neglect) and trauma history have also 
been implicated as factors that increase risk for poor behavioral and psychosocial outcomes 
(Ford et al., 2000). Physical and sexual maltreatment are highly prevalent among children 
diagnosed with ODD and ADHD, with children diagnosed with ODD conferring higher 
prevalence than those diagnosed with ADHD, and those with comorbid ADHD and ODD 
conferring the highest prevalence rate of maltreatment (Ford et al.,2000). The link between 
maltreatment and DBDs is bidirectional and likely complex. On the one hand, the emotional 
dysregulation involved in ADHD and ODD puts children at higher risk for maltreatment, for 
example, by evoking conflict (Angold & Costello, 1996). On the other hand, maltreatment can 
also contribute to and exacerbate deficits in anger and emotional self-regulation (Jennings, van 
der Molen, Pelham, Debski, & Hoza, 1997). Similarly, hyperarousal (as measured by heart rate 
change) resulting from exposure to trauma could further exacerbate deficits in one’s ability to 




negative temperament (Ford et al., 2000). With regard to the relationship between maltreatment 
and poor psychosocial outcomes, De Sanctis and colleagues (2008) found that children with 
ADHD and a history of maltreatment had elevated rates of substance use disorders above and 
beyond the variance that is accounted for by psychiatric comorbidities, parental substance use, 
and low SES. Given that there are high rates of maltreatment reported in ADHD children, it is an 
important factor to consider in poor behavioral and psychosocial outcomes.  
It is clear that environmental factors are related to children’s mental health. Many studies 
support an additive and reciprocal risk model, such that the presence of either ODD/ADHD or 
environmental factors alone do not predict the other. Instead, the presence of financial stressors 
(resulting from unemployment and low SES) as well as parental factors (i.e., psychopathology) 
are associated with higher ADHD and ODD symptom levels. Some children are at higher risk for 
developing behavioral problems, and there are specific factors that are more strongly linked to 
the development of ADHD and ODD as well as mood symptoms. The presence of childhood 
maltreatment and factors contributing to low-SES incur a higher risk for the development of 
disruptive behavior disorders, with specific evidence linked to irritability. What remains to be 
known is the extent to irritability and defiance are associated with these risks.  
Treatment  
Emotion dysregulation affects a large portion of children with ADHD, and increases risks 
for poor outcomes across the lifespan, even for those who remit (Ambrosini et al., 2013; Shaw et 
al., 2014). Findings of a large longitudinal study conducted in Germany which set out to assess 
predictors of psychopharmacological treatment for children with ADHD showed that those 




treatment significantly sooner than those with other types of physical or mental disorders (Garbe 
et al., 2012). Yet, research on the treatment of irritability in an ADHD sample is scarce. The 
potential for interventions that could ameliorate irritability could be informed by the effects of 
psychopharmacological treatments for ADHD on symptoms related to emotion regulation and 
emotional lability. 
Treatment Studies 
Psychostimulants, primarily methylphenidate (MPH) and amphetamines, are the most 
effective and frequently prescribed medications for the treatment of ADHD. However, non-
stimulant medications such as atomoxetine (ATX) have also demonstrated efficacy in reducing 
symptoms of ADHD in several randomized controlled clinical trials (Michelson et al., 2002). 
Stimulant treatment with MPH has consistently been shown to be effective in treating ODD and 
aggression in children with ADHD (MTA Cooperative Group, 1999; Roman et al., 2001; Stein et 
al., 2005) and treatment with ATX has also been shown to be effective in reducing ODD 
symptoms (Mill et al., 2002). However, irritable and defiant symptoms appear to be distinct 
components of ODD in terms of both etiology and outcomes. Thus, it is possible that irritability 
and defiance may require distinct treatments. 
  Findings of stimulant treatment response in children with ADHD and emotion 
dysregulation have been variable. Treatment with MPH has been found to ameliorate emotional 
dysregulation (Fernandez, Simonoff, McGough, Halperin, Arnold, & Stringaris, 2014; 
Biederman et al., 2002; Skirrow, McLoughlin, Kuntsi, & Asherson, 2009). Several randomized 
placebo-controlled clinical trials have demonstrated that treatment with MPH results in reduced 




2011). Furthermore, a study of adults with ADHD and emotionality (i.e., temper, affective 
lability, emotional over reactivity) showed significant improvement in symptoms of ADHD and 
emotionality when treated with MPH (Marchant, Reimherr, Robison, Olsen, Kondo, 2011; 
Reimherr, et al., 2007). In contrast, others have found that stimulant treatment with MPH has no 
effect on emotional symptoms (Gillberg et al., 1997), while others have found that MPH can 
increase mood lability and irritability (Manos et al., 2011; Biederman et al., 2002). In addition, 
whereas some studies of stimulant treatment response in children with ADHD and internalizing 
disorders suggest a lower response rate overall (Greenhill et al., 1996; Greenhill et al., 2002), 
others indicate that the response rate does not differ for those with and without internalizing 
disorders (Greenhill et al., 2001; Newcorn, Spencer, Biederman, Milton, & Michelson, 2005). 
Treatment with non-stimulant medication has received increasing interest given findings 
of potential diversion and substance dependence with stimulant medications (McCabe & West, 
2013) as well as rare but severe adverse reactions (Sonuga-Barke, et al., 2009). Studies of non-
stimulant medications show similar efficacy to that of stimulant medications at treating 
symptoms of emotion dysregulation. A randomized-control study assessing response to ATX in 
adults with ADHD found that ATX demonstrated the same degree of efficacy for the treatment 
of symptoms of ADHD and symptoms of emotion dysregulation (i.e., temper, affective lability, 
emotional over reactivity; Reimherr et al., 2005). Another randomized controlled clinical trial in 
adults with ADHD found that ATX was effective in reducing ADHD symptoms as well as its 
associated emotional lability and emotional dysregulation (Sobanski et al., 2012). While these 
findings of efficacy seem compelling, another randomized-controlled trial comparing ATX to 
placebo in children ages 6 to 7 years-old found no change in emotional symptoms for either 




emotional symptoms in individuals with ADHD, the research on the efficacy of ATX is far too 
scarce to draw definitive conclusions.  
There is a clear need for more research to assess factors which might be contributing to 
mixed findings in the clinical treatment literature. Contributing factors could include 
neurobiological and neurodevelopmental processes in those brain regions which are targeted by 
medications, such as the prefrontal cortex (PFC). Another potential mechanism of improvement 
in emotional control could be changes in neuropsychological abilities such as attention and 
executive functions that underlie changes in behavioral and emotional regulation. Understanding 
the underlying mechanisms that lead to changes in emotion dysregulation following treatment for 
ADHD will be helpful for the clarification of mixed results in the research literature. 
Treatment Targets: The Neurobiology of ADHD and Emotion Dysregulation 
A large body of evidence supports the notion that ADHD is the result of abnormalities in 
the brain’s frontal cortex, the PFC in particular, as well as in the neural circuitry connecting the 
PFC to subcortical structures (i.e., striatum, anterior cingulate cortex, cerebellum). Frontostriatal 
and frontocerebellar circuits are involved in top-down, goal-oriented cognitive control (Nigg & 
Casey, 2005). Frontolimbic circuits are involved in reinforcement learning and conditioning, and 
appear to be linked to impulsive behavior. Variations in concentrations of neurotransmitters (NT) 
as well as in receptor and transporter functions have been proposed to underlie variations in 
phenotypic or behavioral presentations in the three subtypes of ADHD (i.e., inattentive, 
hyperactive/impulsive, and combined type; Martel, Nikolas, Jernigan, Friderici, & Nigg, 2012). 
Genetic research implicates that genes with significant associations to ADHD are involved in the 




(DA) and norepinephrine (NE) (Epstein et al., 2007; Prince, 2008). DA plays an important role 
in one’s cognition and affect, and NE plays an important role in modulating attention, arousal, 
and inhibition (Arnsten, 2006). Adequate functioning of the dopaminergic and noradrenergic 
tracts that connect the PFC to other important brain areas is essential to one’s ability to pay 
attention and regulate behavior (Biederman & Spencer, 1999). Medications for ADHD facilitate 
the transport of NE and DA, resulting in significant improvement in ADHD symptoms, therefore 
supporting the view that ADHD is a catecholaminergic condition (Newcorn et al., 2008). 
Stimulant treatments work to inhibit the catecholamine transporters, thereby increasing the 
amount of DA and NE that is left in the synaptic cleft. Non-stimulant medications such as ATX 
work to inhibit the reuptake of norepinephrine and serotonin at the presynaptic site, again 
resulting in increased levels of norepinephrine (Gilbert et al., 2006).  
Previous studies have also found evidence of the role of serotonin transporters (5-HTT) 
and serotonin (Faraone et al., 2005) in ADHD, and a bidirectional relationship between both DA 
and serotonin (5-HT) in emotion regulation (Davidson, Putnam, & Larson, 2000; Lucki, 1998). 
Serotonergic functioning has also been linked to impulsive behaviors in children with ADHD. 
More specifically, low serotonergic activity correlates with higher levels of impulsive and 
aggressive behavior, while separate and overlapping trends were correlated with cognitive 
impulsivity (Oades et al., 2008).  
While considerable research has replicated findings of the association between DA, NE, 
and 5-HT systems in ADHD, single gene studies present a rather simplified approach that does 
not account for the heterogeneity in phenotypic presentation. Comings and colleagues (2000) 




noradrenergic genes were highly involved in ADHD, noradrenergic and dopamine genes were 
highly involved in CD, and serotonergic genes were highly involved in ODD. Further, 
serotonergic and dopaminergic systems have strong bidirectional anatomical and functional 
interactions in the prefrontal cortex, which have been shown to play a crucial role in the 
regulation of negative emotions (Daw, Kakade, & Dayan, 2002; Phan et al., 2005; Quirk, Russo, 
Barron, & Lebron, 2000; Yan, 2002). Increased levels of DA have been associated with 
impulsivity and emotion dysregulation in patients with mood disorders (Friedel, 2004).  
While the exact mechanism of action by which medications for ADHD improve 
symptoms is unclear, they likely involve facilitation of transmission of dopamine and 
noradrenaline (Bidwell, Dew, & Kollins, 2010), which in turn activates frontostriatal and 
frontolimbic circuits leading to cognitive and affective treatment response.  
The Relation between Cognitive and Affective control in ADHD 
 Cognitive control describes basic processes (e.g., attentional focus, attention orientation) 
which support higher order executive functions (e.g., working memory, inhibitory control, 
cognitive flexibility/ set-shifting, planning) that enable goal-directed behaviors in both the 
cognitive and emotional spheres (Barkley, 1997a; Diamond, 2013). Executive functions 
contribute to the self-regulation of cognitions, emotions, and behavior (Barkley, 2012; Casey, 
2015). Research studies have shown that higher levels of executive control are associated with 
lower levels of externalizing behaviors (Riggs, Blair, & Greenberg, 2003), lower levels of 
negative emotion (Eisenberg et al., 2009; Eisenberg, Eggum, Vaughan, & Edward, 2010), and 
higher levels of social competence (Eisenberg et al., 2010). Notably, stable versus declining 




Degnan, Calkins, & Keane, 2006). The cognitive control of attention has been linked to reacting 
in socially appropriate ways in the face of an emotionally challenging situation (Kieras, Tobin, 
Graziano, & Rothbart, 2005). For example, in order to respond to an emotionally charged 
situation in an adaptive way, perhaps by inhibiting an impulsive and reactive response, one needs 
to be able to direct their attention away from the provoking stimulus and instead consider a goal-
directed response that is socially appropriate. Therefore, emotion regulation/affective control 
relies, at least in part, on executive functioning. 
 Research in developmental neuroscience supports the notion that emotion regulation and 
executive function are linked developmentally. This work has identified specific brain regions 
that play a role in attention, and in cognitive and affective regulation (Posner & Rothbart, 2000). 
Functional neuroimaging studies revealed that both emotion regulation and executive function 
are mediated by areas of the PFC (Blair, Zelazo, & Greenberg, 2005). For example, the anterior 
cingulate cortex (ACC) is involved in cognitive control, specifically related to the processing of 
conflicting information. It is comprised of two subdivisions, which are involved in distinct 
streams of information processing (Posner & Rothbart, 2000). The first subdivision processes 
information from the dorsolateral PFC and is associated with cognitive and attentional control. 
The second subdivision involves the processing of information in the ventromedial, orbitofrontal 
stream which is associated with the limbic system and the control of emotional arousal and 
control. Therefore, the ACC and PFC work together to mediate executive processes involved in 
planning, organizing, monitoring, and goal setting. The functional relation between these circuits 
of processing provides a neurobiological basis for understanding the development of self-
regulatory abilities. Developmental maturation of the PFC and ACC are potential mechanisms 




2002; Ochsner & Gross, 2005). The processes of cognitive and emotional control are 
interdependent and both contribute to the development of optimal self-regulation.  
Currently our understanding of how cognitive and emotional control are related in the 
context of ADHD remains relatively unintegrated. ADHD has been shown to be associated with 
altered development of cortical regions (i.e., delayed maturation; Shaw et al., 2007) and 
subcortical networks including neural circuitry (i.e., reduced neural activity, inappropriate 
signaling during task performance; Dickstein, Bannon, Castellanos, & Milham, 2006). These in 
turn result in disruptions in the functional development of self-regulatory processes. However, 
little is known about the mechanisms that bring about changes in emotion regulation in the 
context of psychopharmacological treatments for ADHD. It is likely that improvements in 
aspects of attention underlie improvements in one’s ability to regulate their emotions. While 
stimulant and non-stimulant treatments for ADHD have been shown to lead to improvements in 
both cognitive and emotional control, findings are mixed, and the extent to which cognitive and 
emotion regulation are linked remains unclear. It appears likely that cognitive and emotional 
control are hierarchically related (Calkins & Keane, 2009; Nigg & Casey, 2005). 
The current study first seeks to determine whether stimulant (methylphenidate; MPH) 
and non-stimulant (atomoxetine; ATX) treatments have different effects on cognitive and 
emotional control in an ADHD sample. Given that MPH has been shown to have a greater 
impact on cognitive control as compared to ATX (Bedard et al., 2015), it is hypothesized that 
emotional control will also improve more with MPH as compared to ATX. Second, we will 
examine whether pre-treatment cognitive control predicts changes in emotional control following 




cognitive control account for improvements in emotional control following treatment with either 
MPH or ATX. Answers to these questions could inform treatment research and lead to the 
development of targeted interventions that could attenuate poor psychiatric and psychosocial 
outcomes.  
Summary and Current Aims 
In sum, irritability is a dimension of behavior that is often present at impairing levels in 
several disorders across the lifespan, and, when occurring in childhood, it is associated with poor 
psychiatric and psychosocial outcomes. The majority of research on irritability has focused on 
adolescents; however, given the heightened risk for impairments and poor outcomes with earlier 
onset of irritability (Perlis et al., 2004), an increased focus on early and middle childhood is 
warranted. Childhood irritability is most central to a diagnosis of ODD, which is highly 
comorbid with ADHD and CD. Many studies have examined children with ADHD and comorbid 
ODD. However, few have applied a dimensional approach considering both affective and 
oppositional dimensions of ODD (irritability and defiance, respectively). Although research has 
examined associations between irritability in adolescence and subsequent adult outcomes, less is 
known about the stability of irritability from childhood through adolescence, and which factors 
may moderate stability and outcomes. Even less is known about the predictive utility of ADHD 
with early irritability or the extent to which psychopharmacological treatment for ADHD might 
improve symptoms of emotion dysregulation in individuals with ADHD. Answers to these 
questions could inform treatment research and lead to the development of targeted interventions 




The current dissertation will address these questions with a focus on the developmental 
stability of symptom dimensions commonly referred to as “irritability,” 
“defiance/headstrongness,” and “vindictiveness/hurtfulness,” and the degree to which the 
presence and variability of these symptom dimensions predict adolescent outcomes and 
treatment response in children with ADHD. The first aim is to examine the developmental 
stability of irritability, defiance, and vindictive symptom dimensions over time from childhood to 
adolescence in a sample of children with ADHD. Assuming variability in findings across youth, 
we will also attempt to identify factors that moderate stability, including environmental factors 
implicated in the literature. The second aim is to determine the extent to which the dimensions of 
irritability, defiance and vindictiveness predict internalizing and externalizing outcomes in 
adolescence in a sample of children with ADHD, and whether environmental factors moderate 
these outcomes. The third aim is to examine the relation between cognitive and emotional 
control, and the extent to which pre-treatment cognitive control and changes in cognitive control 
contribute to changes in emotional control in youth with ADHD following medication treatment. 
Data will be analyzed from a longitudinal sample of clinically referred children 
diagnosed with ADHD when they were 7-11 years old and followed through on average 18 years 
of age (16-21 years-old) to examine questions of stability, predictive utility, risk factors, and 
psychiatric and psychosocial outcomes in children with early irritability, defiance, and 
vindictiveness. Data from a separate sample of clinically referred children (7-17 years-old) 
diagnosed with ADHD and recruited as part of an NIH- funded clinical trial of FDA-approved 
treatments, will be used to determine whether treatment with stimulant and non-stimulants have 
differential effects on emotional control, and the relation between cognitive and emotional 





Given the research on the development of irritability, it is hypothesized that overall 
irritability will be highly stable in this sample. We expect our assessment of outcomes to follow 
research demonstrating strong associations between irritability with internalizing disorders, 
defiance with externalizing disorders and substance use, and vindictiveness with CD. With 
regard to the relation between cognitive and emotional control in the context of 
psychopharmacological treatment for ADHD, it is hypothesized that 1) emotion regulation will 
improve more with stimulant treatment (e.g., methylphenidate) than non-stimulant (e.g., 
atomoxetine) treatment, 2) pre-treatment levels of cognitive control will predict methylphenidate 
but not atomoxetine response, and 3) greater improvements in cognitive control will be 




STUDY 1: The Effects of Childhood Irritability on Adolescent Outcomes  
Irritability has received considerable attention in recent research due to its presence 
across several disorders throughout the lifespan and its association with a range of poor 
psychiatric and psychosocial outcomes. Findings from several longitudinal studies support the 
notion that irritability is highly stable from adolescence to adulthood (Caprara et al., 2007; Frick 
et al., 1993; Leadbeater & Homel, 2015). However, findings from the only study to examine the 
stability of irritability in childhood (Wiggins et al., 2014) revealed that levels of irritability 
fluctuate considerably between the ages of one and nine years. Measuring irritability and closely 
related symptoms between middle childhood and adolescence may be key to understanding 
individual differences in stability, as well as risks for poor outcomes. As such, the aim of the 
current study is to elucidate the developmental stability of, and outcomes associated with 
irritability and closely related behaviors, such as defiance from childhood through adolescence, 
and which factors may moderate stability and outcomes. Answers to these questions could 
inform treatment research and lead to the development of targeted interventions that could 
attenuate poor outcomes. While it would have been of interest to study “vindictiveness” as well, 
it is characterized by only one item in the DSM-5 (APA, 2013), and we were able to construct 
only a 2-item scale from our CBCL data to measure it. This measure had weak reliability as rated 
in childhood and adolescence (Cronbach’s α = .64 and .58, respectively). Given that ratings of 
vindictiveness were based only on two items with marginal inter-item consistency, this variable 
was excluded from the study. 
The majority of research on irritability and its associated impairments has focused on 




irritability (Perlis et al., 2004), an increased focus on early and middle childhood is warranted. 
Childhood irritability is most central to a diagnosis of ODD, which is highly comorbid with 
ADHD and CD. As such, ADHD is closely linked to irritability, as well as other dimensions of 
oppositionality- defiance, and vindictiveness. Little is known about the predictive utility of 
irritability in school-age youth with ADHD on later psychiatric or psychosocial outcomes. One 
study which looked at children with ADHD with and without irritability found that those with 
elevated levels of irritability experienced higher rates of internalizing symptoms as compared to 
individuals with ADHD alone (Ambrosini et al., 2013). While many studies have examined 
outcomes of children with ADHD and comorbid ODD, few have applied a dimensional approach 
considering both affective and behavioral aspects of ODD. Research applying a dimensional 
approach is warranted given the high prevalence of children with ADHD and irritability, and 
particular risk for impairment and poor outcomes across the lifespan, even when symptoms of 
irritability remit (Ambrosini et al., 2013; Shaw et al., 2014).  
Longitudinal studies may be better able to examine the extent to which varying levels of 
irritability are associated with different outcomes, as well as to examine the extent to which the 
presence of potentially moderating factors influence the associations between early irritability 
and later irritability and psychiatric and psychosocial outcomes. Another notable limitation in 
extant research is that most longitudinal studies that measure the stability of irritability have 
focused on community-based samples which tend to have lower levels of symptomatology. 
Utilizing a clinic-referred sample will likely elucidate the relation between varying levels of 
irritability and heterogeneous outcomes in children at greatest risk for poor outcomes.  
Research has also long acknowledged the negative influence of environmental factors on 




development of behavioral and emotional problems in children (Harland et al., 2002). Childhood 
maltreatment and a history of trauma have also been implicated as factors that increase risk for 
poor behavioral and psychosocial outcomes (Ford et al., 2000). On the one hand, behavioral and 
emotional problems in ADHD and ODD put children at greater risk for maltreatment by evoking 
conflict (Angold & Costello, 1996). On the other hand, maltreatment can also exacerbate deficits 
in anger and emotional self-regulation (Jennings et al., 1997). Given that there are high rates of 
maltreatment reported in ADHD children (Ford et al., 2000), it is an important factor to consider 
when examining behavioral, emotional, and psychosocial outcomes in this population. 
The current study will focus on the developmental stability of symptom dimensions of 
irritability and defiance, and the degree to which the presence and variability of these symptom 
dimensions predict adolescent outcomes in a sample of inner-city clinic-referred children with 
ADHD whose lower SES puts them at heightened environmental risk.  
The primary aim is to elucidate the nature of the associations among irritability, 
psychiatric outcomes, psychosocial outcomes, and environmental factors within a developmental 
model. Specifically, this study will examine the longitudinal associations between parent-ratings 
of irritability and the related construct of defiance at school-age and adolescence. The first aim is 
to examine the developmental stability of irritability and defiance, over time from childhood to 
adolescence, in a sample of children with ADHD. The second aim is to determine the extent to 
which parent-rated irritability and defiance in childhood predict self-reported depression, 
anxiety, aggression, and substance use outcomes in adolescence. Moderation models are used to 





Given the research on the development of irritability, it is hypothesized that irritability 
will be highly stable in this sample. Further, we expect positive associations between early 
irritability and later internalizing symptoms, and early defiance and later externalizing outcomes 






The study sample consisted of 80 (70 males) clinically referred children diagnosed with 
ADHD who were evaluated as part of a research protocol which focused on the biological bases 
of ADHD and aggression, conducted between 1990 and 1997 (original N = 169). This subsample 
consisted of those participants who were re-evaluated in adolescence and had both childhood and 
adolescent parent ratings of irritability and defiance as measured by the CBCL. The participants 
were initially recruited from local community schools and clinical referrals from mental health 
workers and school psychologists/social workers. At the time of the initial assessment, children 
were between the ages of 7 and 11 years, and at the time of the follow-up assessment adolescents 
were between the ages of 16 and 21 years. The sample was ethnically diverse and was primarily 
of lower to lower-middle socioeconomic status with a large portion at the poverty level. All 
participants were English-speaking. Children with a diagnosis of schizophrenia, pervasive 
developmental disorder, and Tourette’s syndrome, were excluded from the study. Additional 
exclusion criteria included a Full Scale IQ below 70 as assessed by the Wechsler Intelligence 
Scale for Children-third edition (WISC-III). As is typical of a clinical sample, rates of 
comorbidity in the subsample (N = 80) were relatively high. Descriptive characteristics of the 
sample are presented in Table 1.  
This study was approved by the Institutional Review Boards of the Mount Sinai School 
of Medicine and Queens College, City University of New York. After a complete description of 
the study, written informed consent was obtained from the parents and verbal assent was 




statement of informed consent for participation in the study. Participants were compensated for 
their time and travel expenses.  
Table 1 
Descriptive Characteristics of the Study Sample 
Variable M SD Range 
Age at Childhood    
   Assessment (in years) 
9.05 1.28 7.02-11.60 
Age at Adolescent  
   Assessment (in years) 
18.11 1.32 15.55-20.8 
Time Between       
   Assessments (in years) 
9.07 1.40 6.30-13.50 
Gender M = 70; F = 10   
FSIQ 94.54 14.15 70-126 
SES in Childhood 35.44 17.37 11-85 
SES in Adolescence 44.05 18.11 20-96 
Race    
   Caucasian 21 (26.3%)   
   African American 16 (20.0%)   
   Hispanic 29 (36.3%)   
   Mixed or Other 13 (16.3%)   
Childhood Diagnoses N (%)    
   ADHD 80 (100%)   
   ODD 63 (78.8%)   
   CD 25 (31.3%)   
   Anxiety Disorder 25 (31.3%)   
   Mood Disorder 7 (8.8%)   
Adolescent Diagnoses N (%)    
   ADHD 43 (53.8%)   
   CD 27 (33.8%)   
   Anxiety Disorder 16 (20.0%)   
   Mood Disorder 14 (17.5%)   
 
Measures 
Diagnostic Measures. Childhood diagnoses of ADHD, CD, ODD, anxiety disorders, and 
mood disorders were based on parental responses to either the Diagnostic Interview Schedule for 




DSM-IV (American Psychological Association, 1987; 1994), respectively. Adolescent diagnoses 
of ADHD, CD, anxiety, and mood disorders were based on parent and adolescent responses to 
the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children Present 
and Lifetime Version (KSADS-PL), which reflects diagnostic criteria from the DSM-IV 
(American Psychological Association, 1994). Although childhood diagnoses for those 
participants recruited before 1994 were made based on DSM-III-R criteria, virtually all 
participants would have met DSM-IV criteria for ADHD, Combined type. To examine 
differences due to differing criteria for ADHD between the DSM-III-R and DSM-IV, a review of 
all ADHD symptom data was conducted and revealed that the groups did not differ with regard 
to parent ratings, or in rates of comorbidity (all p > .05; De Sanctis et al., 2008). Diagnostic 
information for the current sample is presented in Table 1.  
Parents also completed the Child Behavior Checklist 6-18 (CBCL; Achenbach, 1991) at 
both childhood and adolescent assessments. The CBCL is a widely used rating instrument that 
assesses both broad and narrow dimensions of childhood psychopathology. It consists of 113 
items which are rated either ‘Never true,’ ‘Sometimes true,’ or ‘Always true.’ The CBCL has 
good test-retest reliability (Pearson’s r = .90) as well as strong internal consistency for both 
narrow and broad band scales (Cronbach’s α = 0.72-0.97; Achenbach, 1991).  
Predictor Variables (Childhood Assessment)  
Childhood Irritability, Defiance, and Vindictiveness. Following the work of Stringaris et al. 
(2012) and Wiggins et al. (2014), we generated separate irritable, defiant, and vindictive 
subscales based on parent ratings on the CBCL. Children’s Irritability score was determined by 




temper,” “stubborn, sullen, or irritable,” and “sudden changes in mood or feelings”) as rated in 
childhood and adolescence (Cronbach’s α = .81 and .82, respectively). The correlation between 
childhood and adolescent irritability was moderate (r = .37, p < .001). Children’s Defiance score 
was determined by the mean score of four items related to defiance on the CBCL (“argues a lot,” 
“disobeys parents,” “defies adult requests,” and “deliberately annoys others”) as rated by parents 
in childhood and adolescence (Cronbach’s α = .77 and .74, respectively). The correlation 
between childhood and adolescent defiance was moderate (r = .38, p < .001). The Vindictive 
score was determined by the mean score of two items related to vindictiveness on the CBCL 
(“cruelty, bullying, or spiteful,” and “destroys things belonging to others”) as rated in childhood 
and adolescence (Cronbach’s α = .64 and .58, respectively). Given that ratings of vindictiveness 
were based only on two items with marginal inter-item consistency, this variable was excluded 
from further analyses. Levels of irritability and defiance in the current sample are presented in 
Table 2. 
Moderator Variables. 
Socioeconomic status. Socioeconomic status (SES) was measured using the Nakao-Treas 
Socioeconomic Prestige Index (Nakao and Treas, 1994), which ranks the relative prestige of an 
individual’s occupation on a scale of 1 to 100. Occupational information was obtained from the 
parents during the childhood and adolescent assessments. Higher scores are indicative of higher 
SES.  
Childhood Maltreatment. Childhood maltreatment was assessed during the follow-up 
evaluation in adolescence using the short form of the Childhood Trauma Questionnaire (CTQ-SF 




abuse and neglect. The CTQ-SF is a brief, reliable, and valid means of retrospectively assessing 
childhood maltreatment, with an internal consistency coefficient ranging from .66 to .92 across 
samples (Bernstein & Fink, 1998; Bernstein et al., 2003). Participants rated statements about 
childhood trauma on a 5-point Likert scale as ‘never true,’ ‘rarely true,’ ‘sometimes true,’ ‘often 
true,’ or ‘very often true.’ Minimization and denial of abuse and neglect are rated on a three-item 
scale that is incorporated into the questionnaire to detect false-negative trauma reports. The 
CTQ-SF assesses five types of maltreatment: emotional abuse, physical abuse, sexual abuse, 
emotional neglect, and physical neglect. The CTQ-SF provides cutoff scores for “none to low,” 
“low to moderate,” “moderate to severe,” and “severe to extreme” exposure for each of the five 
types of maltreatment. For the purposes of this study, a dichotomous variable of yes (maltreated)/ 
no (not maltreated) was created where individuals were categorized as maltreated if they met 
criteria for moderate to severe levels of maltreatment using the cut scores provided in the CTQ 
manual. Prevalence of childhood maltreatment in the current sample is presented in Table 2. 
Dependent Variables (Adolescent Assessment) 
Internalizing Outcomes. 
Depression. Adolescents provided self-reported ratings of the presence of depressive 
symptomatology using the Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996). 
The BDI-II contains 21-items related to various symptoms of depression. Each answer is scored 
on a scale from zero to three, with higher total scores indicating more severe depressive 
symptoms. Standardized cutoffs are as follows: 0-13 indicates minimal depression, 14-19 
indicates mild depression, 20-28 indicates moderate depression, and 29-63 indicates severe 




and high internal consistency (Cronbach’s α= 0.91; Beck et al., 1996). Levels of depression in 
the current sample are presented in Table 2.  
Anxiety. Adolescents provided self-reported ratings of anxious symptomatology on the 
State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). 
The STAI is a 40-item self-report questionnaire that measures both state anxiety (immediate, 
transitory emotional state) and trait anxiety (an enduring disposition to feel stress, worry, and 
discomfort). Items are rated on a 4-point Likert scale, ‘not at all,’ ‘somewhat,’ ‘moderately so,’ 
and ‘very much so.’ Scores range from 20 to 80, with higher STAI scores suggesting higher 
levels of anxiety. Levels of state and trait anxiety in the current sample are presented in Table 2.  
Externalizing Outcomes. 
Aggression. Adolescent aggression was assessed using the Buss Perry Aggression 
Questionnaire (BPAQ; Buss & Perry, 1992), a frequently used self-report inventory for assessing 
hostility and aggression. The BPAQ is a 29-item questionnaire that measures physical 
aggression, verbal aggression, anger, and hostility. Items are rated on a 5-point Likert scale, from 
‘not like me (1)’ to ‘a lot like me (5).’ Scores range from 29 to 145 where higher scores indicate 
higher aggressive behavior. Levels of aggression in the current sample are presented in Table 2.  
Substance Use. Adolescent substance use was assessed using the Rutgers Alcohol and 
Drug Use Questionnaire (RADQ; Labouvie, Bates, & Pandina, 1997). The RADQ assesses 
current and past use of cigarettes, alcohol, marijuana, cocaine, stimulants, and other prescription 
and non-prescription drugs. Respondents report the frequency and amount of drug and alcohol 




confidentiality, the study obtained a certificate of confidentiality from the National Institute of 
Health. The use of cigarettes, marijuana (THC), and alcohol (ETOH) in the previous three years 
was coded as a binary variable of yes/no. Endorsements of cocaine, opiate and stimulant use 
were very low in the sample. Therefore, they were not used in analyses. The prevalence of 
substance use in the current sample is presented in Table 2. 
Table 2  
Descriptive Statistics for Main Study Variables 
 N M SD Range 
Independent Variables     
Childhood Irritability  80 1.20 0.66 0-2 
Childhood Defiance 80 1.35 0.54 0-2 
Moderator Variables     
Maltreatment 76 53 (54.6%)   
Socioeconomic Status 80 35.44 17.37 11-85 
Dependent Variables     
Adolescent Irritability  80 0.92 0.68 0-2 
Adolescent Defiance  77 0.87 0.57 0-2 
Adolescent Depression (BDI-II)   74 9.99  10.26 0-47 
Adolescent State Anxiety (STAI) 75 36.25 11.03 20-66 
Adolescent Trait Anxiety (STAI) 75 38.64 10.67 20-69 
Physical Aggression (BPA) 73 26.06 8.47 10-44 
Verbal Aggression (BPA) 73 17.01 3.98 9-24 
Anger (BPA) 73 19.58 6.67 8-34 
Hostility (BPA) 73 21.03 7.88 8-37 
Tobacco Use 79 41 (42.3%)   
Marijuana Use 79 51 (52.6%)   
Alcohol Use 79 60 (61.9%)   
Note. Childhood variables were assessed between the ages of 7 and 11 years. Adolescent 
variables were assessed between the ages of 16 and 21.Adolescent depression was measured 
using the Beck Depression Inventory (BDI-II). Adolescent state and trait anxiety were measured 
using the State-Trait Anxiety Inventory (STAI). Adolescent aggression was measured using the 







Data Analysis  
The stability of measures of irritability and defiance from childhood to adolescence were 
measured using separate linear regression models, with childhood irritability and defiance as the 
predictors, and adolescent irritability and defiance as the dependent variables. All stability 
analyses controlled for time between assessments. In order to assess for moderators of stability, 
Baron and Kenny’s method of using statistical interaction terms was applied, with irritability and 
defiance in childhood as the predictor (x), and irritability and defiance in adolescence as the 
outcome (y), and each moderator serving as an “interaction” variable (z) (Baron & Kenny, 
1986). Before conducting analyses all predictor and moderating variables were centered by 
subtracting the variable mean from each individual case (see Table 1 for means and standard 
deviations of each variable). The unstandardized regression coefficients were used for 
interpretation of the effect of each moderating factor. The following website was used for 
plotting main effects and interactions (http://pavlov.psyc.vuw.ac.nz/paul-
jose/modgraph/onlinecontcomp.php). 
To determine the extent to which early irritability and defiance predicted internalizing 
and externalizing outcomes in adolescence, separate multiple linear (for continuous outcome 
variables) or logistic regressions (for dichotomous outcome variables) were used with childhood 
ratings as the predictor or independent variable, and adolescent outcomes as the dependent 
variables. Except for substance use measures, time between assessments was not significantly 
correlated with any dependent variable and was therefore not included as a covariate in the other 
analyses. The statistical interaction term was used to examine the potential moderating effects of 





Change and Stability of Irritability and Defiance from Childhood to Adolescence 
 Results of paired samples t- tests revealed that levels of irritability (t (79) = 3.27, p = 
.002) and defiance (t (79) = 6.88, p < .001) decreased significantly from childhood to 
adolescence. Furthermore, results of linear regression revealed that after controlling for time 
between assessments, childhood irritability was a significant positive, although not robust, 
predictor of adolescent irritability, Adjusted R2 = .12, F (2, 77) = 6.20, p = .003. Similarly, after 
controlling for time, childhood defiance was a similarly significant positive predictor adolescent 
defiance, Adjusted R2 = .13, F (2, 77) = 6.64, p = .002.  
Potential Moderators of the Stability of Irritability and Defiance across Childhood and 
Adolescence 
Socioeconomic Status. 
Socioeconomic status was not significantly correlated with adolescent irritability (r (78) 
= -.08, p = .52), but it was significantly associated with adolescent defiance (r (78) = -.23, p = 
.04) in adolescence. 
Irritability. Results of hierarchal linear regressions, presented in Table 3, revealed that 
after controlling for time there was a significant main effect of childhood irritability on 
adolescent irritability. The main effect of SES on adolescent irritability was not significant; 
however, the interaction between childhood irritability and SES was significant.  
In order to understand the nature of the Childhood Irritability x SES interaction as a 
predictor of adolescent irritability, the interaction was plotted and the simple slopes examined. 




medium and high levels of SES. As depicted in the figure, childhood irritability was a significant 
and positive predictor of adolescent irritability in those with high SES (t = 3.66, p < .001) and 
medium SES (t = 3.20, p = .002), but not in those with lower SES (t = 1.00, p = .321).  
Table 3 
Socioeconomic Status (SES) as a Moderator of the Association of Irritable Symptoms  
between Childhood and Adolescence 
Predictor ΔR2 B SE β 
Step 1 .00       
   Time    .01 .06 .01 
Step 2 .15**       
  Time   .04 .05 .08 
  Childhood Irritability   .35 .11 .35*** 
  SES   -.00 .00 -.02 




.01 .00 .24* 
 









Defiance. The results of hierarchal linear regressions, presented in Table 4, revealed that 
after controlling for time there was a significant main effect of childhood defiance on adolescent 
defiance. There was no main effect of SES on adolescent defiance, nor was there a significant 
interaction between childhood defiance and SES. An inspection of the coefficients in the final 
model indicated that childhood defiance positively predicted adolescent defiance. As no 
significant interaction was detected further moderation analysis via simple slopes were not 
conducted, see Figure 2.  
Table 4  
Socioeconomic Status (SES) as a Moderator of the Association of Defiant Symptoms  
Between Childhood and Adolescence 
Predictor ΔR2 B SE β 
Step 1 .00       
 Time    -.02 .05 -.05 
Step 2 .16*       
  Time   -.03 .04 -.07 
  Childhood Defiance   .36 .12 .34* 
  SES   -.01 .00 -.10 




.00 .01 .07 
 





Figure 2. SES does not moderate the relation between childhood and adolescent defiance. 
Childhood Maltreatment.  
An inspection of the correlations between childhood maltreatment and adolescent 
irritability and defiance indicated that the presence of maltreatment was significantly associated 
with irritability (r (67) = .24, p = .04) and defiance (r (67) = .33, p = .006) in adolescence. The 
results of an independent samples t-test, presented in Table 5, revealed that the mean level of 
SES did not vary for those with as compared to those without a history of maltreatment.  
Table 5 
t-test Results Comparing the Level of SES and the History of Maltreatment  
Maltreatment 
History 
n M SD t df p 
Yes 47  35.00  17.56  .71 68 .48 
No 23  38.30  19.75     
Note. SES = Socioeconomic Status. SD = Standard Deviation.  
Irritability. After accounting for time between assessments, the results of a regression 




maltreatment, and their interaction significantly predicted adolescent irritability. However, an 
inspection of the coefficients indicated that neither childhood irritability, history of maltreatment, 
nor the interaction between these variables independently significantly predicted adolescent 
irritability. Thus, further moderation analyses via simple slopes were not conducted. Figure 3 
illustrates the relation between irritability in childhood and adolescence for those with and 
without a history of maltreatment. 
Table 6  
Maltreatment as a Potential Moderator of the Stability of Irritability between Childhood and 
Adolescence 
Note. N = 70. * p < .01. Time = Time between Assessments.  
 
Predictor ΔR2 B SE Β 
Step 1 .00       
  Time    -.02 .06 -.04 
Step 2 .14*        
  Time  -.02 .06 -.04 
  Childhood Irritability   .32 .19 .33 
  Maltreatment   .26 .16 .19 
  Childhood Irritability X Maltreatment   .05 .24 .04 





Figure 3. Maltreatment does not moderate the relation between childhood and adolescent 
irritability.  
Defiance. After accounting for time between assessments, the results of a regression 
analysis (see Table 7) indicated significant main effects of childhood defiance and childhood 
maltreatment on adolescent defiance. The interaction between childhood defiance and 
maltreatment was not significant. An inspection of the coefficients revealed that both childhood 
defiance and maltreatment positively predicted adolescent defiance. As no significant interaction 
was detected, further moderation analyses via simple slopes were not conducted. Figure 4 
illustrates the relation between defiance in childhood and adolescence for those with and without 










Table 7  
Childhood Maltreatment as a Potential Moderator of the Stability of Defiance from Childhood 
through Adolescence 
Predictor ΔR2 B SE Β 
Step 1 .01       
  Time    -.04 .05 -.06 
Step 2 .17**       
  Time  -.04 .05 -.06 
  Childhood Defiance   .47 .17 .44** 
  Maltreatment   .32 .14 .28* 




-.31 .24 -.16 
 
Note. N = 65.*p < .05, ** p < .01. Time = Time between Assessments. 
 
 
Figure 4. Maltreatment does not moderate the relation between childhood and adolescent 
defiance. 
 
Potential Moderators of the Relations between Childhood Irritability and Defiance in 




Socioeconomic Status.  
 Table 8 shows that adolescent ratings of depressive symptoms were not significantly 
associated with childhood or adolescent levels of irritability or defiance, or socioeconomic status. 
Table 8 
Correlations between Adolescent Depression and Irritability and Defiance in Childhood and 
Adolescence  
 Childhood 










-.04 -.04 .10 .07 .06 
Note. N = 74. SES = Socioeconomic Status.  
Irritability. Results of a multiple regression analysis, presented in Table A1 (see 
Appendix A), indicated that the overall model including main effects of childhood irritability, 
SES, and the interaction between these variables did not significantly predict ratings of 
adolescent depressive symptoms. 
Defiance. Results of a multiple regression analysis, presented in Table A2, indicated that 
the overall model including main effects of childhood defiance, SES, and the interaction between 
these variables did not significantly predict ratings of adolescent depressive symptoms.  
Childhood Maltreatment. 
The results of an independent samples t-test, presented in Table 9, revealed that 
adolescent ratings of depressive symptoms were significantly higher for individuals with as 







t-test Results Comparing Ratings of Depressive Symptoms in Adolescence and the Presence of a 
History of Maltreatment  
Maltreatment 
History 
n Mean SD t df p 
Yes 45  12.07  11.33  2.34 66 .02 
No 23  6.04  6.76     
Note. N = 68. SD = Standard Deviation 
 
Irritability. Results of a multiple regression analysis, presented in Table 10, indicated that 
childhood maltreatment, but not irritability, was a significant predictor of adolescent ratings of 
depressive symptoms. When the Childhood Irritability X Maltreatment variable was added, the 
overall model was no longer significant. An inspection of the coefficients in the initial model 
indicated a positive relation such that adolescent ratings of depressive symptoms were 
significantly higher for individuals with as compared to those without a history of maltreatment.  
Table 10  
Maltreatment as a Potential Moderator of the Relation between Childhood Irritability and 
Adolescent Depression  
Predictor  ΔR2 B SE β 
Step 1 .09*       
  Childhood Irritability   -1.98 1.84 -.13 
  Maltreatment   6.45 2.60 .30* 
Step 2 .01       
  Childhood Irritability   -.52 3.14 -.03 
  Maltreatment   6.22 2.64 .29* 
  Childhood Irritability X Maltreatment     -.23 3.88 -.12 
Total R2 .10    
Note. N = 68. * p < .05. 
Defiance. The results of a regression analysis (see Table 11) indicated that again there 
was a significant main effect of maltreatment on adolescent ratings of depressive symptoms. 




maltreatment significantly predicted adolescent ratings of depressive symptoms. As no 
significant interaction was detected, further moderation analyses via simple slopes were not 
conducted. Figure 5 illustrates the relation between childhood defiance and ratings of depressive 
symptoms in adolescence for those with and without a history of maltreatment. 
Table 11 
Maltreatment as a Potential Moderator of the relation between Childhood Defiance and 
Adolescent Depression  
Predictor  ΔR2 B SE Β 
Step 1 .10*       
  Childhood Defiance   -2.71 2.27 -.14 
  Maltreatment   6.56 2.60 .30* 
Step 2 .03*       
  Childhood Defiance   .23 3.11 .01 
  Maltreatment   6.34 2.59 .29* 
  Childhood Defiance X Maltreatment  -6.20 4.53 -.22 
Total R2 .12*    
Note. N = 68. * p < .05.  
 
Figure 5. Maltreatment does not moderate the relation between childhood defiance and 




Relations and Potential Moderators of the Relations between Irritability and Defiance in 
Childhood and Anxious Symptoms in Adolescence 
 Table 12 shows that neither adolescent state nor trait anxiety was associated with 
childhood or adolescent levels of irritability or defiance, or SES.  
Table 12 













-.04 .01 .10 .04 -.13 
Adolescent 
Trait Anxiety 
-.08 -.06 .13 .07 .02 
Note. N = 75. SES = Socioeconomic Status. 
 Irritability. The results of separate multiple regression analyses, presented in Tables A3 
and A4, indicated that the overall models including childhood irritability, SES, and the 
interaction between these variables did not significantly predict adolescent ratings of state nor 
trait anxiety.  
Defiance. The results of separate multiple regression analyses, presented in Tables A5 
and A6, indicated that the overall models including childhood defiance, SES, and the interaction 
between these variables did not significantly predict adolescent ratings of state nor trait anxiety.  




As shown in Tables 13 and 14, there were no significant differences in adolescent ratings 
of state and trait anxiety for individuals with as compared to those without a history of 
maltreatment.  
Table 13  
t-test Results Comparing Ratings of State Anxiety in Adolescence and the Presence of a History 
of Maltreatment  
Maltreatment 
History 
n Mean SD t df p 
Yes 45  36.35  11.49  -.18 66 .89 
No 23  36.84  10.40     
Note. N = 68. SD = Standard Deviation 
Table 14 
t-test Results Comparing Ratings of Trait Anxiety in Adolescence and the Presence of a History 
of Maltreatment  
Maltreatment 
History 
n Mean SD t df p 
Yes 45  40.24  10.72  -1.51 66 .14 
No 23  36.13  10.40     
Note. N = 68. SD = Standard Deviation 
Irritability. The results of a multiple regression analysis, presented in Table A7 indicated 
that the overall model including childhood irritability, maltreatment, and the interaction between 
these variables did not significantly predict adolescent ratings of state anxiety. 
The results of a separate multiple regression analysis, presented in Table 15, indicated 
that neither childhood irritability nor a history of maltreatment emerged as significant predictors 
of ratings of trait anxiety in adolescence. However, the interaction between the variables did 
emerge as a significant predictor. To understand the nature of the Childhood Irritability X 
Maltreatment interaction as a predictor of adolescent ratings of trait anxiety, the interaction was 
plotted and the simple slopes examined. Figure 6 illustrates the relation between childhood 




maltreatment. As depicted in the figure, childhood irritability negatively predicted adolescent 
trait anxiety for those who endorsed a positive history of maltreatment in childhood, (t (64) =-
2.25, p = .30). For those who endorsed a negative history of maltreatment in childhood, 
childhood irritability was unrelated to adolescent trait anxiety (t (64) = 1.06, p = .30).  
Table 15 
Maltreatment as a Potential Moderator of the relation between Childhood Irritability and 
Adolescent Trait Anxiety 
Predictor ΔR2 B SE Β 
Step 1 .05       
  Childhood Irritability   -2.25 1.94 -.14 
  Maltreatment   4.60 2.74 .21 
Step 2 .07*       
  Childhood Irritability   3.38 3.20 .21 
  Maltreatment   3.73 2.70 .17 




-8.62 3.96 -.44* 
 
Note. N = 68. * p < .05.  
 





Defiance. The results of separate multiple regression analyses, presented in Tables A8 
and A9, indicated that the overall models including childhood defiance, maltreatment, and the 
interaction between the variables did not significantly predict adolescent ratings of state nor trait 
anxiety. 
Potential Moderators of the Relations between Irritability and Defiance in Childhood and 
Aggression in Adolescence 
 Table 16 shows that childhood irritability was significantly associated with adolescent 
self-report of physical aggression and anger. Childhood defiance was significantly related to 
adolescent self-report of physical aggression. Adolescent irritability and adolescent defiance 
were each significantly associated with adolescent self-report of physical aggression, verbal 
aggression, and anger.  
Table 16 
Correlations between Ratings of Irritability and Defiance and Adolescent Aggression 
Controlling for Time between Assessments 
 Childhood 








Physical Aggression  .23*  .28* .32** .42*** -.34** 
Verbal Aggression  .15 .06 .26* .32** -.02 
Anger  .30* .19 .33** .44*** -.14 
Hostility  -.05 -.07 .06 .13 -.14 







As shown in Table 16, SES was significantly negatively associated with adolescent self-
report of physical aggression. SES was not significantly associated with Verbal Aggression, 
Anger or Hostility. 
Irritability. Results of a multiple regression analysis, presented in Table 17, revealed that 
the overall model including childhood irritability, SES, and their interaction significantly 
predicted adolescent physical aggression. There was a significant main effect of SES on physical 
aggression in adolescence. Neither childhood irritability nor the interaction between the variables 
was significant. An inspection of the coefficients in the final model indicated that SES negatively 
predicted physical aggression in adolescence. As no significant interaction was detected further 
moderation analysis via simple slopes were not conducted. Figure 7 illustrates the relation 
between childhood irritability and adolescent physical aggression across levels of SES (i.e., low, 
medium, high). As depicted in the figure, childhood SES was negatively related to ratings of 
adolescent physical aggression irrespective of childhood irritability. 
Results of a separate multiple regression analysis, presented in Table 18, revealed a 
significant main effect of childhood irritability on self-reported anger in adolescence. Neither 
SES nor the interaction between the variables was significant. An inspection of the coefficients 
in the final model indicated that childhood irritability positively predicted anger in adolescence. 
As no significant interaction was detected further moderation analysis via simple slopes were not 
conducted. Figure 8 illustrates the relation between childhood irritability and adolescent anger 
across levels of SES (i.e., low, medium, high). As depicted in the figure, childhood irritability 




Additionally, the results of separate multiple regression analyses, presented in Tables B1 
and B2, indicated that neither childhood irritability, SES, nor the interactions between these 
variables emerged as significant predictors of self-reported verbal aggression or hostility in 
adolescence.  
Table 17 
Socioeconomic Status (SES) as a Moderator of the association between Childhood Irritability 
and Adolescent Physical Aggression 
Predictor ΔR2 B SE Β 
Step 1 .16*       
  Childhood Irritability   2.65 1.38 .21 
  SES   -.15 .05 -.33* 
Step 2 .00*       
  Childhood Irritability   2.60 1.41 .21 
  SES   -.15 .05 -.33* 




.01 .07 .02 
 











Socioeconomic Status (SES) as a Moderator of the association between Childhood Irritability 
and Adolescent Anger 
Predictor ΔR2 B SE Β 
Step 1 .10*       
  Childhood Irritability   2.85 1.12 .29* 
  SES   -.05 .04 -.12 
Step 2 .45       
  Childhood Irritability   2.72 1.14 .27* 
  SES   -.05 .04 -.13 




.04 .06 .09 
 
Note. N = 73. * p < .05.  
 
 
Figure 8. SES does not moderate the relation between childhood irritability and adolescent 
anger.  
 
Defiance. Results of a multiple regression analysis, presented in Table 19, revealed that 
the overall model including childhood defiance, SES and their interaction significantly predicted 
adolescent physical aggression. There was a significant main effect of SES on self-reported 
ratings of physical aggression in adolescence. Neither childhood defiance nor the interaction 




indicated that SES negatively predicted physical aggression in adolescence. As no significant 
interaction was detected further moderation analysis via simple slopes were not conducted. 
Figure 9 illustrates the relation between childhood defiance and adolescent physical aggression 
across levels of SES (i.e., low, medium, high).  
Additionally, the results of separate multiple regression analyses, presented in Tables B3-
B5, indicated that none of the models including childhood defiance, SES, nor the interactions 
between these variables emerged as a significant predictor of self-reported verbal aggression, 
anger, or hostility in adolescence.  
Table 19 
Socioeconomic Status (SES) as a Moderator of the association between Childhood Defiance and 
Adolescent Physical Aggression 
Predictor ΔR2 B SE Β 
Step 1 .16**       
  Childhood Defiance   3.37 1.71 .22 
  SES   -.14 .05 -.30** 
Step 2 .01       
  Childhood Defiance   3.10 1.76 .20 
  SES   -.13 .05 -.28* 




.06 .09 .08 
 







Figure 9. SES does not moderate the relation between childhood defiance and adolescent 
physical aggression. 
 Maltreatment.  
Results of separate t-tests (Tables B6 – B9) indicated that there were no significant 
differences in adolescent ratings of aggression for individuals with as compared to those without 
a history of maltreatment.  
Irritability. Results of separate multiple regression analyses, presented in Tables 20 and 
21, revealed significant main effects of childhood irritability on self-reported physical aggression 
in adolescence. Neither maltreatment nor the interaction between the variables was significant. 
An inspection of the coefficients in the final model indicated that childhood irritability positively 
predicted physical aggression and anger in adolescence. As no significant interactions were 
detected further moderation analyses via simple slopes were not conducted.  
Additionally, the results of separate multiple regression analyses, presented in Tables 




these variables emerged as significant predictors of self-reported verbal aggression or hostility in 
adolescence.  
Table 20 
Maltreatment as a Moderator of the association between Childhood Irritability and Adolescent 
Physical Aggression 
Predictor ΔR2 B SE Β 
Step 1 .10*       
  Childhood Irritability   2.75 1.48 .22 
  Maltreatment   3.23 2.11 .18 
Step 2 .02       
  Childhood Irritability   5.29 2.54 .43* 
  Maltreatment   2.85 2.14 .16 




-3.87 3.10 -.25 
 




Maltreatment as a Moderator of the association between Childhood Irritability and Adolescent 
Anger 
Predictor ΔR2 B SE Β 
Step 1 .12*       
  Childhood Irritability   2.89 1.17 .29* 
  Maltreatment   2.09 1.68 .15 
Step 2 .12       
  Childhood Irritability   3.78 2.02 .38 
  Maltreatment   1.96 1.70 .14 




-1.35 2.49 -.11 
 
Note. N = 68. * p < .05. 
 
Defiance. Results of a multiple regression analysis, presented in Table 22, revealed that 
the overall model including childhood defiance, maltreatment and their interaction was a 
significant predictor of adolescent physical aggression. There was a significant main effect of 
childhood defiance on self-reported ratings of physical aggression in adolescence. Neither 




coefficients in the final model indicated that childhood defiance positively predicted physical 
aggression in adolescence. As no significant interaction was detected further moderation analysis 
via simple slopes were not conducted. Figure 10 illustrates the relation between childhood 
defiance and adolescent physical aggression for individuals with and without a history of 
childhood maltreatment. Although the interaction was not significant (p = .115), as depicted in 
the figure, at lower levels of defiance, those who endorsed a positive history of maltreatment 
reported greater levels of physical aggression as compared to those who did not endorse a history 
of maltreatment. At higher levels of defiance, there was not much of a difference between those 
who endorsed a positive history of maltreatment as compared to those who did not endorse a 
history of maltreatment. 
Additionally, the results of separate multiple regression analyses, presented in Tables 
B12-14 indicated that neither childhood defiance, maltreatment, nor the interactions between 
these variables emerged as significant predictors of self-reported verbal aggression, anger or 
hostility in adolescence.  
Table 22 
Maltreatment as a Moderator of the association between Childhood Defiance and Adolescent 
Physical Aggression 
Predictor ΔR2 B SE Β 
Step 1 .12*       
  Childhood Defiance   4.28 1.82 .28* 
  Maltreatment   3.00 2.08 .17 
Step 2 .03       
  Childhood Defiance   7.00 2.47 .45** 
  Maltreatment   2.80 2.08 .16 




-5.75 3.60 -.25 
 






Figure 10. Maltreatment does not moderate the relation between childhood defiance and 
adolescent physical aggression. 
Potential Moderators of the Relations between Irritability and Defiance in Childhood and 
Substance Use in Adolescence 
Socioeconomic Status. 
Substance Use. As shown in Table 23, SES did not differ significantly between 
adolescents who did and did not report cigarette or alcohol use. However, SES was significantly 
lower for adolescents who did as compared to those who did not report marijuana use. 
Table 23  
t-test Results Comparing Socioeconomic Status and the Presence of Adolescent Substance Use 
Substance Category n Mean SD t df p 
Cigarettes- Yes 40  33.04  18.01  1.42 75 .16 
Cigarettes- No 37  38.78  17.45     
Marijuana- Yes 50  32.21  15.98 2.48 75 .02 
Marijuana- No 27  42.44  19.52     
Alcohol- Yes 58  36.25  18.31  -.39 75 .70 
Alcohol- No 19  34.42  16.83     




Irritability. The results of a logistic regression analysis, presented in Table 24 revealed 
significant main effects of time between assessments and childhood irritability on adolescent 
cigarette use. An inspection of the coefficients indicated that both time and childhood irritability 
positively predicted the presence of engaging in adolescent cigarette use. As no significant 
interaction was detected further moderation analysis via simple slopes were not conducted.  
The results of a logistic regression analysis, presented in Table 25, revealed significant 
main effects of SES on adolescent marijuana use. An inspection of the coefficients indicated that 
SES negatively predicted the presence of engaging in marijuana use in adolescence. As no 
significant interaction was detected further moderation analysis via simple slopes were not 
conducted. 
Additionally, the results of a separate logistic regression analysis, presented in Table 26 
indicated that neither childhood irritability, SES, nor the interactions between these variables 
emerged as significant predictors of alcohol use in adolescence.  
Table 24  
Socioeconomic Status (SES) as a Moderator of the Relation between Childhood Irritability and 
Adolescent Cigarette Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
   Time .40 .19 4.28 1.49 (1.02, 2.18)* 
   Childhood Irritability .82 .39 4.46 2.26 (1.06, 4.83)* 
   SES -.02 .01 1.34 .98 (.96, 1.01) 
   Childhood Irritability X SES .01 .02 .37 1.01 (.97, 1.05) 
  Constant -2.95 1.84 2.58 .052 










Socioeconomic Status (SES) as a Moderator of the Relation between Childhood Irritability and 
Adolescent Marijuana Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .23 .19 1.42 1.26 (.86, 1.85) 
  Childhood Irritability .31 .39 .64 1.37 (.64, 2.92) 
  SES -.03 .01 4.84 .97 (.94, 1.00)* 
  Childhood Irritability X SES -.001 .02 .001 .96 (.96, 1.04) 
  Constant -.30 1.84 .03  
Note. N = 77. * p < .05.  
Table 26 
Socioeconomic Status (SES) as a Moderator of the Relation between Childhood Irritability and 
Adolescent Alcohol Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .37 .22 2.69 1.44 (.93, 2.24) 
  Childhood Irritability .78 .43 3.30 2.19 (.94, 5.08) 
  SES .01 .02 .26 1.01 (.98, 1.04) 
  Childhood Irritability X SES -.02 .02 .57 .98 (.94, 1.03) 
  Constant -2.40 2.11 1.30  
Note. N = 77.  
 
Defiance. The results of a logistic regression analysis, presented in Table 27, revealed 
significant main effects of childhood defiance on adolescent cigarette use. An inspection of the 
coefficients indicated that childhood defiance positively predicted the presence of engaging in 
adolescent cigarette use. As no significant interaction was detected further moderation analysis 
via simple slopes were not conducted.  
The results of separate logistic regression analyses, presented in Tables 28 and 29, 
indicated that neither childhood irritability, SES, nor the interactions between these variables 







Socioeconomic Status (SES) as a Moderator of the Relation between Childhood Defiance and 
Adolescent Cigarette Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
   Time .36 .19 3.40 1.43 (.98, 2.08) 
   Childhood Defiance 1.25 .53 5.55 3.49 (1.23, 9.87)* 
   SES -.01 .02 .40 .99 (.96, 1.02) 
   Childhood Defiance X SES .04 .03 1.53 1.04 (.98, 1.11) 
  Constant -2.76 1.86 2.20  
Note. N = 77. * p < .05.  
Table 28 
Socioeconomic Status (SES) as a Moderator of the Relation between Childhood Defiance and 
Adolescent Marijuana Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .23 .20 1.33 1.26 (.85, 1.84) 
  Childhood Defiance .78 .50 2.43 2.19 (.82, 5.86) 
  SES -.03 .02 3.03 .97 (.95, 1.00) 
  Childhood Defiance X SES .02 .03 1.02 1.02 (.97, 1.07) 
  Constant -.41 1.88 .05  
Note. N = 77.  
Table 29 
Socioeconomic Status (SES) as a Moderator of the Relation between Childhood Defiance and 
Adolescent Alcohol Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .37 .23 2.70 1.45 (.93, 2.25) 
  Childhood Defiance .94 .52 3.30 2.56 (.93, 7.09) 
  SES .02 .02 .83 1.02 (.98, 1.05) 
  Childhood Defiance X SES .00 .03 .00 1.00 (.95, 1.06) 
  Constant -2.67 2.14 1.56  
Note. N = 77.  
 Maltreatment. 
Results of chi-square analyses revealed that the presence of childhood maltreatment was 
significantly related to cigarette use in adolescence (X2 (1) = 11.60, p = .001), but not to 




Adolescent cigarette use was significantly greater in those with a positive history of 
maltreatment in childhood. 
Irritability. The results of a logistic regression analysis, presented in Table 30, revealed 
significant main effects of childhood irritability and maltreatment on adolescent cigarette use 
(See Figure 11). An inspection of the coefficients indicated that childhood irritability and 
maltreatment positively predicted the presence of adolescent cigarette use. As no significant 
interaction was detected further moderation analysis via simple slopes were not conducted.  
The results of separate logistic regression analyses, presented in Tables 31 and 32, 
indicated that neither childhood irritability, maltreatment, nor the interactions between these 
variables emerged as significant predictors of the presence of marijuana or alcohol use in 
adolescence. 
Table 30 
Maltreatment as a Moderator of the Relation between Childhood Irritability and Adolescent 
Cigarette Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .44 .25 3.18 1.55 (.96, 2.50) 
  Childhood Irritability 2.24 1.14 3.86 9.37 (1.01, 87.43)* 
  Maltreatment 2.16 .74 8.45 .12 (.03, .50)** 
  Childhood Irritability X Maltreatment -1.84 1.24 2.22 .16 (.01, 1.79) 
  Constant -3.27 2.16 2.28  






Figure 11. Main effects of childhood irritability and maltreatment on adolescent cigarette use 
 
Table 31 
Maltreatment as a Moderator of the Relation between Childhood Irritability and Adolescent 
Marijuana Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .23 .21 1.23 1.26 (.84, 1.91) 
  Childhood Irritability  .89 .68 1.75 2.44 (.65, 9.17) 
  Maltreatment -.71 .57 1.55 .49 (.16, 1.50) 
  Childhood Irritability X Maltreatment -.99 .84 1.38 .37 (.07, 1.94) 
  Constant -1.16 1.89 .37  
Note. N = 69.  
Table 32 
Maltreatment as a Moderator of the Relation between Childhood Irritability and Adolescent 
Alcohol Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .35 .25 1.89 1.42 (.86, 2.33) 
  Childhood Irritability  .19 .67 .08 1.21 (.33, 4.49) 
  Maltreatment -.89 .63 2.02 .41 (.12, 1.41) 
  Childhood Irritability X Maltreatment 1.01 .91 1.22 2.74 (.46, 16.28) 
  Constant -1.57 2.23 .49  





Defiance. The results of a logistic regression analysis, presented in Table 33, revealed 
significant main effects of maltreatment on adolescent cigarette use (See Figure 12). An 
inspection of the coefficients indicated that the presence of a history of maltreatment predicted 
the presence of engaging in adolescent cigarette use. As no significant interaction was detected 
further moderation analysis via simple slopes were not conducted.  
The results of separate logistic regression analyses, presented in Table 34 and 35, 
indicated that neither childhood defiance, maltreatment, nor the interactions between these 
variables emerged as significant predictors of marijuana or alcohol use in adolescence. 
Table 33 
Maltreatment as a Moderator of the Relation between Childhood Defiance and Adolescent 
Cigarette Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .37 .23 2.54 1.45 (.92, 2.27) 
  Childhood Defiance 2.40 1.45 2.73 10.97 (.64, 187.85) 
  Maltreatment 2.17 .78 7.76 8.72 (1.90, 39.99)** 
  Childhood Defiance X Maltreatment -1.89 1.61 1.37 .15 (.01, 3.57) 
  Constant -4.89 2.25 4.72  
Note. N = 71. * p < .05, ** p < .01.  
 
Table 34 
Maltreatment as a Moderator of the Relation between Childhood Defiance and Adolescent 
Marijuana Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .20 .21 .96 1.23 (.82, 1.85) 
  Childhood Defiance 1.21 .72 2.86 3.37 (.83, 13.74) 
  Maltreatment .65 .56 1.34 1.91 (.64, 5.76) 
  Childhood Defiance X Maltreatment -1.24 1.02 1.48 .29 (.04, 2.14) 
  Constant -1.60 1.93 .68  








Maltreatment as a Moderator of the Relation between Childhood Defiance and Adolescent 
Alcohol Use 
Predictor B SE Wald test OR (95% CI) 
Step 1        
  Time .32 .25 1.66 1.38 (.85, 2.25) 
  Childhood Defiance .20 .66 .09 1.22 (.33, 4.45) 
  Maltreatment .83 .60 1.91 2.30 (.71, 7.45) 
  Childhood Defiance X Maltreatment .89 1.09 .67 2.44 (.29, 20.71) 
  Constant -2.22 2.27 .96  












The aims of the current study were to 1) elucidate the developmental stability of 
irritability and defiance from childhood through adolescence in a sample of youth with ADHD; 
2) determine adolescent outcomes associated with childhood irritability and defiance in youth 
with ADHD; and 3) examine which factors may moderate stability and outcomes. Answers to 
these questions could inform treatment research and lead to the development of targeted 
interventions that could attenuate poor outcomes. 
Overall, the data indicate that within an ADHD sample, both irritability and defiance are 
moderately stable from childhood through adolescence/early adulthood, and that the stability of 
irritability, but not defiance, was moderated by SES such that it was most stable in those with 
higher SES. Contrary to our hypotheses, neither irritability nor defiance in childhood predicted 
later internalizing problems, although both predicted later externalizing problems (e.g., anger, 
aggression) and cigarette use. While lower SES and history of maltreatment increased risk for 
later externalizing and substance use problems, neither of them moderated the relations between 
childhood irritability/defiance and these outcomes. 
Stability 
Recent literature has examined the stability of irritability over time with the hope of 
elucidating the developmental course of irritability and its relation to the emergence of related 
psychopathology. The current study is the only one, as far as we know, that examines the 
stability of irritability and its related constructs (i.e., defiance) between childhood and 
adolescence within a clinical sample. Consistent with our first hypothesis, results indicated that 
irritability demonstrated moderate stability from childhood through adolescence, although the 




early childhood (Wiggins et al., 2014) and the high stability characteristic of the transition from 
adolescence to adulthood (Caprara et al., 2007; Leadbeater & Homel, 2015). Childhood defiance 
was also found to maintain moderate stability during this time. Given high rates of comorbidity 
between ADHD and disruptive behaviors throughout the lifespan (Nordstrom et al., 2013), the 
stability of defiance might be characteristic of the current sample population.  
This is the first study to examine environmental moderators of the stability of irritability 
and defiance. Findings indicated that those in lower SES showed less stability in affective 
symptoms over time. Being in a lower SES, which in this sample is equated with welfare status, 
is typically associated with greater environmental variability which increases the risk for the 
development of emotional problems. However, this was not the case for behavioral symptoms as 
SES did not moderate the stability of defiance in this sample. That said, the main effect for SES 
indicates an additive effect such that defiant children from lower SES families are likely to have 
the most elevated levels of adolescent defiance. Maltreatment did not moderate the stability of 
irritability or defiance; however, like SES, it did predict significantly higher levels of defiance in 
adolescence. Therefore, the presence of environmental risk factors can influence the 
development and maintenance of irritability and defiance through both direct and interactive 
pathways.  
Internalizing Outcomes 
The current study did not replicate findings in the existing literature that childhood 
irritability was the sole predictor of depression and anxiety, as compared to the headstrong and 
hurtful dimensions of behavior. Given that we utilized the same constellation of symptoms found 
to demonstrate predictive validity of childhood irritability in previous research, (Stringaris & 




in sample characteristics. Stringaris & Goodman (2009a, 2009b) utilized cross-sectional data 
from two community based samples from the large British Child and Adolescent Mental Health 
Survey which consisted of children ranging from ages 5 to 15 years, a much wider age range 
than that of the current study (Ford, Goodman, & Meltzer, 2003; Green et al., 2005). Rowe et al. 
(2010) examined the longitudinal associations between irritability and headstrongness at nine 
years old and later internalizing outcomes seven years later in a community-based sample. They 
found that irritability predicted anxiety, but not depression, and that headstrongness predicted 
depression, CD, and substance use. While community based samples are important for 
characterizing typical developmental levels of a construct, they tend to have lower levels of 
overall symptomatology as compared to clinical samples. In addition, caution is required when 
attempting to draw causal inferences from cross-sectional samples. In contrast, the current study 
utilized longitudinal data from a well-characterized clinical sample of children diagnosed with 
ADHD when they were 7 to 11 years old who were re-evaluated nearly 10 years later when they 
were 16 to 21 years old. Although irritability was defined the same way in all three studies, it is 
important to consider the diverse origins of irritability between the samples. Specifically, it is 
possible that for children diagnosed with behavioral disorders (ADHD, ODD, CD), irritability 
stems from a characteristic resistance to comply with adult demands, tendencies towards 
coercion, and difficulties with self-regulation. In contrast, the irritability present in a community-
based sample may be more related to general levels of affective distress and negative emotional 
reactivity (e.g., dysphoria, anxious symptoms). Therefore, the irritability in Stringaris’ and 
Rowe’s samples may have been more associated with internalizing symptoms and not with 
externalizing symptoms. Indeed, only 9.5% of Stringaris’ sample met criteria for at least one 




indicating that they failed to meet full diagnostic criteria but experienced symptoms that were 
causing significant impairment or distress (Ford et al., 2003). Therefore, divergent findings in 
longitudinal outcomes of irritability between these samples might highlight subtle differences in 
the origins of irritability.  
 The study samples also differed in important demographic factors that are known to 
contribute to the prevalence, severity, and persistence of psychiatric symptomatology. At least 
half of the sample utilized by Stringaris & Goodman (2009a, 2009b) consisted of families 
defined as being in the middle to upper-middle class (i.e., gross weekly household income 
greater than $300 British pounds). Only one-third of the sample in Burke’s study fell in the low 
SES range (Burke, 2012). In contrast, the current sample largely consisted of low-SES families. 
In light of the current findings that SES moderated the stability of irritability, the contribution of 
SES to divergent findings is likely substantial. We found irritability to be less stable in those 
youth with lower SES, raising the possibility that Stringaris’ sample had greater stability in 
irritability as compared to the current sample. This could also contribute to the different 
developmental associations with later internalizing outcomes.  
In addition, developmental associations between internalizing disorders are known to 
differ between genders (Burke et al., 2010). The gender ratio for depression increases greatly in 
early adolescence, when females’ rates begin to exceed those of males’. Females also experience 
a different course of depression than males (Hankin et al., 1998). For example, whereas negative 
temperament in young boys is predictive of later oppositional behavior, negative temperament in 
young girls has been shown to increase risk for internalizing disorders (Keenan & Shaw, 1994). 
The sample utilized by Stringaris and colleagues consisted of 50% males, whereas the current 




utilized by Stringaris and colleagues likely contributes to differences in rates of depression as 
well as the associations with internalizing outcomes overall.  
A more pertinent study for comparison is that of Burke (2012), which examined the 
predictive utility of irritability (angry, spiteful, touchy), oppositionality (often loses temper, 
argues, defies), and antagonism (annoys others, blames others) in a clinic-referred sample of 7-
12 year old males with DBDs. Burke found that irritability predicted depression and anxiety at 
age 18 years. Despite the greater similarity in sample characteristics, only 50% of Burke’s 
sample met criteria for an ADHD diagnosis at baseline as compared to the current study’s 100% 
ADHD diagnosis. That said, there was an important methodological difference between the 
studies. Irritability was defined as angry, spiteful, and touchy, but lacked the characteristic of 
losing temper, and arguing with adults, which were instead included under their construct of 
oppositionality along with defiance. Although Burke and colleagues arrived at these constructs 
based on the results of factor analyses, other studies (Stringaris & Goodman, 2009; Rowe et al., 
2010) instead found that losing temper is a characteristic of affectively oriented problems, and 
spitefulness is not. Therefore, Burke and colleagues measured constructs that differed both 
operationally and conceptually from those used in previous studies and the current study. 
Findings that childhood defiance did not predict depression or anxiety in adolescence are 
contrary to other findings in the literature (Burke, 2012; Leadbeater & Homel, 2015). 
Importantly, in the current sample, 11 adolescents (14.9%) endorsed experiencing moderate to 
severe depressive symptoms (BDI scores above 13; total score range 0-47), 29 (38.7%) endorsed 
state anxiety that was above the clinical cutoff, and 32 (42.7%) indicated trait anxiety that was 
above the clinical cutoff (STAI state and trait scores above 39; total score range 20-69). 




literature for an ADHD sample (Ambrosini et al., 2013). Specifically, an overwhelming majority 
(78%) of the sample had comorbid ODD and a third of the sample (30%) presented with a 
comorbid internalizing disorder in childhood.  
The lack of an association between higher levels of childhood irritability and adolescent 
internalizing symptoms may suggest that early irritability has a differential influence on the 
development of internalizing symptoms in an ADHD sample. While the current sample did 
experience comorbidities to an extent that is characteristic of an ADHD sample, it is likely that 
the strong presence of disruptive behaviors functions to identify a different subgroup of children 
as compared to those in community-based samples that present with irritability. While several 
studies have indicated a high prevalence of irritability in ADHD children, irritability does not 
confer the presence of a mood disorder (Mick, Spencer, Wozniak, & Biederman, 2005; Galanter 
et al., 2003; Geller et al., 2002).  
Current findings suggest that the link between maltreatment and DBDs is complex, and 
research has shown a bidirectional relation (Ford et al., 2000). While the presence of 
maltreatment moderated the relation between irritability and anxiety, the negative relation was 
surprising and hard to explain. Among children who were not maltreated, findings are consistent 
with previous studies of longitudinal associations (Burke et al., 2010; Leadbeater & Homel, 
2015; Stringaris and Goodman, 2009a; Whelan et al., 2013). Higher irritability was associated 
with greater anxiety. However, in children who were maltreated, the relation appears much 
different such that higher irritability is associated with less anxiety in adolescence. One could 
speculate several possible reasons for this. First, given the number of analyses conducted, this 
could be a chance finding. A second potential explanation is that irritability may be masked or 




the sample. The youth with lower, but not higher, levels of irritability who endorsed 
maltreatment in childhood reported significantly greater levels of physical aggression and anger 
in adolescence, which potentially masked their internalizing symptoms.  
In addition, the presence of maltreatment in childhood contributed to significantly higher 
adolescent depressive symptoms in the current sample. These findings support research showing 
the pathways between hostile and negative parenting with childhood behavior problems, which 
in turn can result in internalizing problems (Shaw & Gross, 2007; Moretti & Osbuth, 2009). The 
current findings contribute to research examining the role of environmental factors in the relation 
between irritability and later internalizing symptoms (Stringaris et al., 2012).  
Externalizing Outcomes 
Childhood irritability significantly and positively predicted physical aggression, anger, 
and cigarette use in adolescence. SES did not moderate the relation between childhood irritability 
and adolescent aggression; however, lower levels of childhood SES significantly predicted 
higher ratings of adolescent physical aggression. Maltreatment did not moderate the relation 
between childhood irritability and aggression. Regarding substance use outcomes, neither SES 
nor maltreatment emerged as moderators.  
Childhood defiance significantly and positively predicted physical aggression and 
cigarette use in adolescence. Although SES did not emerge as a moderator, as indicated above, 
lower levels of SES significantly predicted higher ratings of physical aggression in adolescence. 
Maltreatment did not emerge as a moderator of the relation between defiance and any form of 
adolescent aggression. However, trends emerged which warrant further discussion. Those who 
experienced maltreatment in childhood reported greater levels of physical aggression overall. For 




predicted significantly higher levels of physical aggression. Neither SES nor maltreatment 
emerged as moderators of the relation between childhood defiance and adolescent substance use 
outcomes.  
Positive associations between early irritability and defiance and later externalizing 
outcomes were in line with findings of previous studies (12 to 20 years old, Caprara et al., 2007; 
12 to 18 years old, Leadbeater & Homel, 2015). The link between defiance and poor behavioral 
outcomes is well-established in both community and clinical samples as young as 3-years-old 
(Ezpeleta, Granero, de la Osa, Penelo, & Domènech, 2012). Defiance is characterized by 
argumentativeness, non-compliance, and rule breaking behavior. Therefore, it is not surprising 
that defiance is a component of several disruptive behavior disorders (ODD, CD), and has 
demonstrated longitudinal associations with persistent disruptive and antisocial behaviors (Aebi 
et al., 2010; Kim-Cohen et al., 2003; Nock et al., 2007; Stringaris & Goodman, 2009).  
Several longitudinal epidemiological studies have found associations between adolescent 
irritability and externalizing outcomes including ODD and ADHD (Leibenluft et al., 2006; 
Mulraney et al., 2014, 2016), CD (Stringaris & Goodman 2009), aggression in young adulthood 
(Caprara et al., 2007), and antisocial behaviors in adolescence and young adulthood (Eley, 
Lichtenstein, & Moffitt, 2003; Leibenluft & Stoddard, 2013). The association between irritability 
and externalizing outcomes has been shown in clinical ADHD samples (Ambrosini et al., 2013; 
Sobanski et al., 2010). The early emergence of physical aggression is an important risk factor for 
outcomes of developmental trajectories of ADHD, which include delinquent and aggressive 
behavior (Loeber et al., 1997). Relations between childhood irritability, aggression, and anger 
found in the current study are consistent with the conceptualization of ADHD as a disorder that 




and irritability have higher rates of substance use than other psychiatric populations (Copeland et 
al., 2014). While irritability has not always been found to predict substance use outcomes in 
community samples (Rowe et al., 2010), research in clinical ADHD samples have found that the 
presence of early irritability is linked to increased severity of substance use disorders (Sobanski 
et al., 2010).  
The current findings are consistent with the extant literature demonstrating that children 
with histories of maltreatment have elevated rates of substance use disorders in adolescence 
(Liebshutz et al., 2002). Previous findings with this ADHD population found elevated rates of 
substance use in those who were maltreated as compared to those with ADHD but no 
maltreatment, with the latter having rates consistent with those reported in the general population 
(De Sanctis et al., 2008). Taken together, our findings suggest that the presence of maltreatment 
plays an important role in substance use outcomes above and beyond the presence of ADHD 
alone. 
As shown in previous studies, ODD could not be subtyped based on irritable and defiant 
symptoms (Rowe et al., 2010). It is rare to find a case that consists of a majority of symptoms of 
irritability or defiance, but not both. Youth in the current study presented with symptoms of 
irritability and defiance, rather than representing two mutually exclusive groups of children. 
Nevertheless, the revised criteria for ODD in DSM 5 highlight that the disorder is characterized 
by both affective and behavioral symptomatology. Continued consideration of the separate 
contributions of each dimension offers the potential of highlighting important differences that 
could be used in the development of person-centered approaches to treatment interventions.  
Irritability and defiance both share aspects of negative affectivity, poor impulse control, 




increases in defiance, and they remained highly correlated in adolescence. Therefore, it is 
difficult to disentangle the influence that irritability and defiance exert on each other, and to 
assess the extent to which each dimension contributes to outcomes of aggression and substance 
use. Previous developmental research measuring the interrelations of ODD sub-dimensions in an 
epidemiological sample found that defiance at age 10 maintained a stronger association with 
irritability at age 13 than the converse, and thus concluded that defiance was likely driving the 
variability of irritability in adolescence (Whelan et al., 2013). The relationship between ODD-
dimensions and a range of outcomes are further complicated by findings of differential effects at 
different developmental stages in a separate community-based sample. Specifically, irritability 
was strongly related to internalizing disorders over time through adolescence and adulthood; 
however, while defiance was associated with both internalizing and externalizing problems in 
adolescence, it only maintained a strong association with internalizing disorders through 
adulthood (Leadbeater & Homel, 2015). Also relevant is other research that examined 
developmental trajectories of irritability from early to middle adolescence in a community-based 
sample, which found that irritability exerted a higher influence on hostile rumination (tendency 
to store ill-feelings and to desire vengeance) than the converse and therefore concluded that 
irritability is a precursor of hostile rumination (Caprara et al., 2007). Stringaris and colleagues 
argue that strong phenotypic links share underlying genetic underpinnings, and that the genetic 
relation between irritability and delinquency was due to the strong correlation between irritability 
and defiant behaviors (Stringaris et al., 2012).  
 The findings of the current study provide an important perspective regarding the 
developmental relation between irritability and defiance and their contribution to behavioral 




irritability, defiance, and outcomes since community-based samples tend to have lower levels of 
symptomatology overall. The homotypic continuity between irritability and internalizing 
outcomes was not maintained in a clinical-ADHD sample. However, early affective symptoms 
maintained associations with externalizing outcomes. Therefore, it appears that early irritability 
and defiance are both stable over time and associated with aggression and substance use through 
adolescence in an ADHD-sample. Thus, both irritability and defiance contribute to the 
emergence of poor behavioral outcomes in ADHD.  
Clinical Implications 
In contrast to study hypotheses, the current findings do not fully support the homotypic 
continuity of early irritability as a predictor for internalizing symptoms in adolescence in an 
ADHD population. This has several clinical implications. First, irritability is only one feature of 
several that define depression and anxiety. The endorsement of irritability is not equivalent to 
meeting full diagnostic criteria for depression or anxiety. Therefore, to assume that the presence 
of irritability is an indicator of the presence of a mood disorder would be an oversimplification. 
Second, findings of studies that examined irritability in ADHD samples support the examination 
of irritability as a dimensional trait in terms of severity as outlined in the NIMH Research 
Domain Criteria (RDOC) initiative. Third, the current findings contribute to other research 
indicating that irritability manifests differently in an ADHD sample (Burke et al., 2010; Mick et 
al., 2005). Therefore, clinicians working with ADHD youth should be mindful to monitor 
irritability as it is a predictor of worse externalizing outcomes, but does not signal a mood 
disorder as has been suggested in other populations (e.g., Bipolar Disorder, disruptive mood 




Research has shown a high prevalence of less-impairing irritability in a large majority of 
children with ADHD in the absence of a mood disorder (Mick et al., 2005; Galanter et al., 2003; 
Geller et al., 2002). In light of the current findings, it is possible that the irritable symptoms often 
concurrent with ADHD are not specifically related to mood disorder, and instead reflect a “low 
frustration tolerance.” Core symptoms of ADHD including impulsivity and difficulty inhibiting 
responses contribute to reduced frustration tolerance. The present study also determined that 
environmental factors moderate affective and behavioral outcomes in ADHD. There is a large 
literature which supports the idea that behavioral and affective regulation is dependent upon 
environmental input and social interaction (Halperin & Healey, 2011). Patterson (1982) argues 
that the relationship between environment and behavioral problems is a bidirectional and 
dynamic process. According to Patterson’s model, hyperactive-impulsive behaviors often trigger 
the use of harsh parenting strategies, which ultimately negatively reinforce misbehavior. 
Furthermore, the presence of environmental risk factors including low SES and poor parenting 
practices (i.e. maltreatment) can further elicit irritability. For example, children with ADHD are 
repeatedly told “Don't do that!” and are therefore frequently being frustrated. When combined 
with low tolerance for frustration, irritability is perpetuated. Therefore, irritability in ADHD may 
manifest more as poor frustration tolerance rather than moodiness. 
 The relation between irritability and aggression has been illustrated in the Frustration-
Aggression hypothesis (Miller, 1941), which states that aggressive behavior is elicited by 
frustration. It follows that a low capacity to tolerate frustration can underlie the tendency to react 
aggressively in response to slight provocation. When considered in a developmental framework, 
irritability can be traced to the neurobiological roots of anger regulation (Caspi & Shiner, 2008). 




early emotion dysregulation. A variety of temperamental factors contribute to one’s tendency 
towards frustration, and hyperactivity and impulsivity are most often cited (Hirshfeld-Becker et 
al., 2002; Sobanski et al., 2010). Therefore, the constellation of ADHD symptoms and irritability 
increases one’s vulnerability to a trajectory that leads to aggressive reactions later. The additional 
presence of irritability can indicate an even greater likelihood of the progression to adult 
antisocial behaviors. Researchers have also suggested that a subset of ADHD youth with 
aggression, emotion lability, impulsivity, and cognitive deficits that are associated with frontal 
lobe dysfunction (Executive Functions) are at highest risk for these poor outcomes. 
Strengths and Limitations  
 The current study has several notable strengths including the well-characterized, 
clinically-referred sample and the long-term follow up period. This is especially important 
because most studies have used community-based samples, which may not reflect how 
constructs manifest in clinical samples. Therefore, the current findings may be more clinically 
applicable. Although various aspects of the sample were a strength, it is not known whether the 
current findings would generalize to a non-ADHD sample.  
In addition, the current sample largely consisted of low-SES families, with a large portion 
of youth having endorsed a positive history of maltreatment. These sample characteristics 
allowed for the assessment of salient environmental risk factors as contributors to the effects of 
irritability and defiance on later pathology. However, the population was primarily of an urban 
lower to middle-class socioeconomic status which may also limit the extent to which findings 
generalize to other populations.  
While many studies have examined outcomes of children with ADHD and comorbid 




aspects of ODD. Research applying a dimensional approach is warranted given the high 
prevalence of children with ADHD and irritability, and particular risk for impairment and poor 
outcomes across the lifespan (Ambrosini et al., 2013; Shaw et al., 2014).  
With regard to methodology, we used contemporaneous assessment methods and 
diagnostic criteria in our baseline and follow-up assessment. The study used a measure of 
aggression designed to capture a wide array of aggressive behaviors including physical 
aggression, verbal aggression, sexual aggression, and hostility.  
The current findings must be considered in light of methodological limitations. The 
sample was restricted to a predominantly male population with ADHD, therefore limiting the 
extent to which conclusions generalize to females. Second, the overall sample size was restricted 
and therefore the relatively small sample size may have limited the ability to detect significant 
results.  
We defined the constructs of irritability, defiance, and hurtfulness based on previously 
validated symptom criteria (Stringaris & Goodman, 2009). However, these constructs contain 
only a few items each, and while these scales had moderate internal consistencies, they only 
demonstrated mediocre reliability. Furthermore, the items were derived from ODD symptom-
criteria. Future research would benefit from using more comprehensive scales of each construct 
to better differentiate between the three dimensions and refine the predictive validity of each 
dimension.  
 While the longitudinal design allowed for the examination of irritability and defiance 
with an appreciation for their developmental course, there were only two time points of 
measurement, which did not allow for the assessment of differential trajectories (requiring at 




 Although considerable data support the reliability and validity of the CTQ, the use of 
retrospective interviews, such as the one used to determine childhood history of maltreatment, 
may be subject to the respondent’s bias (i.e., social desirability, mood at time of report) and 
forgetting (Babor, Brown, & Del Boca, 1990). 
The present study did not control for possible contributory effects of CD or familial 
factors (parental history of psychopathology). The presence of CD and other psychiatric 
comorbidities have been established as potent risk factors for externalizing outcomes in several 
studies of ADHD youth (Barkley, Fischer, Smallish, & Fletcher, 2004), and should be considered 
in future investigations.  
Finally, if irritability is in fact manifested differently in youth with ADHD, the changes 
proposed in the DSM 5 regarding subgroups of children with ODD may potentially reduce the 
accuracy with which clinicians consider the development of internalizing problems. Future 
research which focuses on evaluating irritable and defiant dimensions should evaluate whether 
additional indicators of irritability would improve predictions of outcomes among children with 
ADHD. In addition, examining the relation between levels of internalizing and externalizing 
symptoms and the subsequent emergence of irritability and defiance is an interesting area of 
further research. 
  The present findings shed light on important gaps in the literature regarding the relation 
between irritability and psychopathology. For example, the need for assessment of stability and 
outcomes associated with both affective and behavioral symptoms which are measured 
dimensionally between childhood and adolescence within a clinically-referred sample. In 
addition, the consideration of moderators of stability as we all internalizing and externalizing 




STUDY 2: The relation between cognitive and emotional control and the Impact of 
Stimulant and Non-Stimulant Medications 
Attention-deficit/hyperactivity disorder (AD/HD) has long been considered a 
neurodevelopmental disorder that results from deficits in behavioral and emotional self-
regulation (Barkley & Murphy, 2006). Core ADHD symptoms, particularly 
hyperactive/impulsive symptoms, have been shown to have significant positive associations with 
the increasing severity of emotional dysregulation (Sobanski et al., 2010). Emotion dysregulation 
affects an estimated 25-50% of children with AD/HD (Ambrosini et al., 2013; Shaw et al., 2014), 
and the presence of emotion dysregulation in children with ADHD has been shown to increase 
the risk for poor outcomes. Specifically, children with ADHD and irritability have been shown to 
have higher rates of ODD, mood disorders, and anxiety disorders, as compared to non-irritable 
children with ADHD (Ambrosini et al., 2013). Other studies have found more widespread 
impairments in peer relationships, family functioning, academic performance, and occupational 
attainment for individuals with ADHD and emotion dysregulation (Wehmeier et al., 2010), even 
after controlling for comorbid disorders.  
Several theories attempt to explain the profile of cognitive and affective weaknesses in 
individuals with ADHD (Barkley, 1997a; Sagvolden, Johansen, Aase, & Russell, 2005). For 
example, cognitive, attentional, and emotional control are hypothesized to be hierarchically 
organized and linked over time, such that the development of earlier regulatory abilities (i.e., 
physiological regulation, attentional control) support the development of later abilities (i.e., 
emotional control; Calkins & Keane, 2009). Nevertheless, it has been posited that cognitive and 
behavioral functioning may be relatively independent in ADHD (Coghill et al., 2014). While 




research is needed in order to refine the conceptions of the cognitive and affective processes 
implicated in ADHD. Specifically, we know that the processes are related and depend on one 
another; however, our understanding of these developmental processes has not been applied 
within the context of treatment. Research of this kind is particularly important in light of the fact 
that children with ADHD and comorbid emotional difficulties seek psychopharmacological 
treatment for their symptoms significantly sooner than those with other types of disorders (Garbe 
et al., 2012). While research on the treatment of irritability in an ADHD sample is scarce, the 
potential for an intervention that could ameliorate irritability could be informed by the effects of 
psychopharmacological treatments for ADHD on emotion regulation.  
Psychostimulants, primarily methylphenidate (MPH) and amphetamines, and non-
stimulant medications such as atomoxetine (ATX) have demonstrated efficacy in reducing 
ADHD symptoms as well as affective symptoms (Mill et al., 2002; MTA Group, 1999); 
however, results of treatment for children with ADHD and emotion dysregulation have been 
variable. Whereas some randomized clinical trials have demonstrated that treatment with MPH 
resulted in reduced irritability and emotional lability (Chacko et al., 2005; Fernandez et al., 2014; 
Manos et al., 2011), others have shown the opposite effect such that MPH increased irritability 
and mood lability (Biederman et al., 2002). Still, others have found no effect on emotional 
symptoms (Gillberg et al., 1997). Studies of non-stimulant medications show similar variability 
in treatment response; whereas results of one randomized clinical trial showed significant 
efficacy for the treatment of symptoms of emotion dysregulation in an ADHD sample (Reimherr 
et al., 2005), another trial showed no change in emotional symptoms following treatment with 
ATX (Kratochvil et al., 2007). It is important to consider that irritability was first examined as a 




consequence of treatment, others found that irritability tended to improve. Research is needed to 
elucidate factors that are contributing to mixed findings. Contributing factors could include 
neuropsychological processes sub-served by brain regions targeted by medications, such as self-
regulatory abilities that are mediated by the prefrontal cortex. Elucidating the relation between 
cognitive and emotional control in the context of treatment will be important for understanding 
the effects of ADHD medication treatment on emotion dysregulation and potentially shed light 
on why so many children with ADHD remain functionally impaired despite improvements in 
core ADHD symptoms.  
The primary aim of the current study is to examine the relation between cognitive and 
emotional control in the context of psychopharmacological treatment for ADHD. This study 
utilized a sample of 72 clinically referred children (7-17 years old) diagnosed with ADHD and 
recruited as part of an NIH-funded clinical crossover trial of FDA-approved treatments who were 
randomized to receive OROS methylphenidate or atomoxetine for ADHD. Comprehensive 
evaluations including measures of behavioral and emotional functioning were conducted prior to 
the start of treatment and again following dose optimization. The first aim is to examine the 
extent to which pre-treatment measures of cognitive control predict changes in emotional control 
following treatment with stimulant and non-stimulant medications. The second aim will address 
the mechanisms of change in emotional control following treatment. This will be done by 
determining the extent to which changes in selected measures of cognitive control account for 
change in emotional control following treatment with stimulant and non-stimulant medication. 
Given that MPH has been shown to have a greater impact on cognitive control as compared to 
ATX (Bedard et al., 2015), and that cognitive and emotional control are hierarchically related 




stimulant treatment (e.g., methylphenidate) than non-stimulant (e.g., atomoxetine) treatment, 2) 
pre-treatment levels of cognitive control will predict methylphenidate but not atomoxetine 
response, and 3) greater improvements in cognitive control will be associated with greater 
improvements in emotional control following treatment. 
Methods 
Participants 
 The study sample consisted of 72 (56 males) children with DSM-IV diagnosis of ADHD, 
any subtype, who participated in a larger crossover trial to evaluate the comparative efficacy and 
predictors of response to OROS methylphenidate (MPH) and atomoxetine (ATX). A 
comprehensive evaluation of behavioral and cognitive functioning was administered pre-
medication and at the conclusion of the treatment block. The total number of children 
randomized to receive either MPH or ATX at the beginning of the study was 232. The 72 
children comprising the current study population represents the subsample of participants who 
completed a measure of emotional control at both pre- and post-treatment evaluations. To reduce 
the likelihood of order effects and to maintain sample size, only data from the first treatment 
block was used. 
The participants were recruited in New York City. Parents gave written consent and 
youth gave verbal assent to participate; the study was approved by the Mount Sinai School of 
Medicine Institutional Review Board. Exclusionary criteria included a Full Scale IQ below 75 as 
assessed by the Wechsler Intelligence Scale for Children- fourth edition (WISC-IV), non-English 
speaking parent or child, neurological dysfunction, chronic medical illness, uncorrected sensory 




exclusionary provided that ADHD was the primary diagnosis and the comorbid condition did not 
require medication treatment. Participants may have been previously treated with MPH or ATX 
but must not have been non-responders to an adequate trial and must not have experienced 
disabling adverse effects with either medication. The majority of participants were medication 
naïve at the pre-treatment evaluation (65%). Descriptive characteristics of the sample are 
presented in Table 1. 
All participants were treated with both MPH and ATX, in a randomized, double blind, 
double dummy, counterbalanced, crossover design (Figure 1). Two capsules of OROS MPH or 
matching placebo and either two or three capsules of ATX (determined by the child’s weight) or 
matching placebo were administered each morning. Weekly ratings of ADHD symptoms and 
severity of impairment were obtained by blind raters who were trained research assistants, 
graduate students, or postdoctoral fellows using the ADHD-RS (DuPaul et al., 1998), which was 
used to track changes in frequency and severity of symptoms during treatment, and aid in clinical 
decision making. A reduction in symptoms >50% was considered good improvement. 
Medication was titrated using a flexible, stepped dose optimization strategy in weekly sessions, 
based on assessment of clinical status and adverse effects, following a pre-established algorithm 
to a standard of no room for improvement. There were four dose levels for each drug (OROS 
MPH: 18mg, 36 mg, 54 mg, 72 mg; ATX: 0.5 mg/kg, 1.0 mg/kg, 1.4 mg/kg, and 1.8 mg/kg). The 








Descriptive Characteristics of the Study Sample 
Variable Total Sample (N = 72) 
Mean (SD) 
MPH (N = 39)  
Mean (SD) 
ATX (N = 33)  
Mean (SD) 
Range 
Age 9.9 (2.7) 10.0 (2.8) 9.8 (2.7) 6.5-17.5 
Gender M = 56; F = 16 M = 32; F = 7 M = 24; F = 9  
Time on drug 
(Days) 
 52.8 (18.3) 54.7 (18.0) 17-107 
Socioeconomic 
Status 
34.7 (16.0) 34.8 (18.6) 34.6 (12.5) 2.5-62.0 
FSIQ 97.76 (11.0) 98.1 (10.6) 97.4 (11.7) 71-126 
Race 
   African 
American 
   Asian 
   Biracial 
   Hispanic 

























    
   ODD 40.3% 46.2% 33.3%  
   CD 6.9% 10.3% 3.0%  
   Anxiety 2.8% 2.6% 3.0%  
   Mood 5.6% 7.7% 3.0%  
Pre-Treatment       
   ADHD Total 
39.2 (9.2) 39.3 (9.0) 39.1 (9.5) 19-54 
Post-Treatment 
   ADHD Total 
16.7 (12.8) 16.7 (13.5) 16.7 (12.1) 1-50 
Note. MPH = Methylphenidate. ATX = Atomoxetine. ADHD Totals are based on total scores on 
the Attention Deficit Hyperactivity/Disorder Rating Scale (ADHD-RS). There was no significant 





Figure 1. Schematic of study design.  
Measures 
Diagnostic Measures. ADHD diagnosis was determined by the Kiddie Schedule for 
Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime Version 
(KSADS-PL) semi-structured interview, during which the clinician evaluated parent’s responses 
to each of the 18 DSM-IV ADHD symptoms as well as contextual and impairment criteria 
(Kaufman et al., 1997). A clinician-rated ADHD- RS severity score of 1.5 SD above age and 
gender means for either the inattention or hyperactivity/impulsivity scales (DuPaul et al., 1998) 
was additionally required. Diagnostic impressions derived from these measures were confirmed 
by a child psychiatrist or psychologist based upon clinical interview and review of all assessment 
information. 
Parents also rated the severity of various disruptive behaviors using the Child Behavior 
Checklist 6-18 (CBCL; Achenbach, 1991) at the pre-treatment assessment to describe the sample 
and offer some basis for examining similarities and differences between this sample and others. 
6.14 Weeks (2.60) 




The CBCL is a widely used rating instrument that assesses both broad and narrow dimensions of 
childhood psychopathology. It consists of 113 items which are rated either ‘Never true,’ 
‘Sometimes true,’ or ‘Always true.’ The CBCL has good test-retest reliability (Pearson’s r = .90) 
as well as strong internal consistency for both narrow and broad band scales (Cronbach’s α = 
0.72-0.97; Achenbach, 1991). Table 2 presents mean pre-treatment ratings of irritability for the 
total sample and by treatment group. 
Socioeconomic status. Socioeconomic status (SES) was measured using the 
Hollingshead Four Factor Index of Socioeconomic Status (Hollingshead, 1975), which considers 
four domains including marital status, employment status, educational attainment, and 
occupational prestige. Parents provide this information as part of the KSADS assessment. Higher 
scores are indicative of higher SES.  
Cognitive Control.  
Continuous Performance Test. Participants were administered Conners’ Continuous 
Performance Test II Version 5 (CPT II: Conners, 2000), a computer-administered task that 
requires participants to respond to 360 letters which appear on the monitor, one at a time, for 250 
msec. Participants are instructed to press the space bar whenever any letter except “X” appears, 
which happens on 10% of trials. The interstimulus interval varies among one, two, or four 
seconds across 18 blocks of 20 trials each. The CPT provides an objective measure of inattention 
and impulsivity. T-scores for age and sex were generated for indices of sustained attention 
including omission errors (i.e., failure to respond to non-Xs), mean response time (mean RT), 
response time variability (RT standard error), detectability (d’; i.e., the ability to distinguish 




assess response inhibition. T- Scores above 60 reflect impairments in these abilities. The CPT 
has been shown to be sensitive to the effects of stimulant (Epstein et al., 2006) and non-stimulant 
medication (Barry et al., 2009). Table 2 presents mean ratings of cognitive control variables for 
the total sample and by treatment group at both pre-treatment and post-treatment assessments. 
Emotional Control. Emotional control was measured using parent ratings on the Social 
Skills Rating System Parent Form (SSRS-P; Gresham & Elliot, 1990). The elementary school 
version is a 38-item, behavior rating system that measures children’s social behavior including 
social skills and problem behavior. We used the self-control subscale which contains items 
measuring how well the child can self-regulate their emotions. This includes a total of 10 
questions related to the regulation of emotion (e.g. responds appropriately when hit or pushed by 
other children, controls temper). Parents rate the items on a 3-point scale (0 = never, 1 = 
sometimes, 2 = very often) according to how frequently the child engages in each behavior. The 
current study utilized the raw scores of the self-control subscale. Higher scores indicate better 
abilities in this area. The SSRS has well-established internal consistency. The subscale “self-
control” showed internal consistency ranging from .88 to .85 for males and females in the parent 
elementary form (ages 8-12 years) and .90 to .89 for males and females in the secondary form 
(ages 13-18 years; Gresham & Elliot, 1990). Table 2 presents mean ratings of emotional control 












Descriptive Statistics for Main Study Variables 
Variable Total Sample  
(N =72)  
Mean (SD) 
MPH  
(N = 39)  
Mean (SD) 
ATX  
(N = 33)  
Mean (SD) 
Range 
Pre-treatment     
Irritability .79 (.61) .78 (.61) .79 (.61) 0-2 
Emotional 
Control 
9.2 (3.95) 8.4 (3.7) 10.15 (4.1) 2-19 
Working 
Memory 




67.01 (23.88) 63.20 (20.29) 71.46 (27.17) 30.49-
120 
Mean RT 54.54 (14.43) 53.60 (14.15) 55.64 (14.91) 27.73-
86.88 
RT Variability 62.52 (11.64) 61.55 (10.78) 63.66 (12.65) 34.27-
86.25 




51.65 (10.27) 52.76 (10.29) 50.35 (10.26) 33.67-
115 
Note. MPH = Methylphenidate. ATX = Atomoxetine. RT = Response time. * p < .05 
Data Analysis 
Change scores for emotional control were computed by subtracting scores on the Post-
treatment evaluation day from scores on the pre-treatment evaluation day. For all computed 
change scores, larger positive difference scores reflect greater improvements in emotional 
control and cognitive control. All cognitive control variables were checked for outliers. 
Tabachnik and Fidell’s (1989) most conservative score changing option was selected when 
subjects had a T-score >100. Each outlier score was changed to equal the next highest score in 
the distribution, plus one unit. Thus, the score remained as the most extreme in the distribution 




points [this was applied to 12 of the 127 observations], and was only applicable for omission 
error T-scores.  
To test Hypothesis 1 that emotion regulation will improve more with stimulant treatment 
(e.g., methylphenidate) than non-stimulant (e.g., atomoxetine) treatment, a mixed-model factorial 
ANOVA was used with drug as the between subjects factor, and time point (pre- and post-
treatment) as the within subjects factor. The dependent measure is the SSRS rating of Self-
control at pre- and post-treatment. Hypothesis 2 posits that pre-treatment levels of cognitive 
control will predict change in emotional control following treatment with MPH but not ATX. 
Separate stepwise regressions were used in order to examine the extent to which pre-treatment 
cognitive control variables predicted change in emotional control following treatment with MPH 
and ATX. Change in emotional control was entered as the dependent variable. Pre-treatment 
cognitive control variables were entered as the predictor variables. A probability less than or 
equal to .05 was required for inclusion in the model. A cutoff probability value of .10 was used 
for the removal of variables from the model. Hypothesis 3 posited that greater improvements in 
cognitive control will be associated with greater improvements in emotional control following 
treatment. There was no a-priori hypothesis as to whether this would vary as a function of drug. 
Change in emotional control was entered as the dependent variable, and change scores for 
cognitive control were entered as predictor variables. Statistical significance was set at the 0.05 





Examining differential effects of drug on changes in emotional control following treatment 
Results of a mix-model factorial ANOVA indicated there was a significant within-
subjects, main effect of Time, F (1, 70) = 32.50, p < .001, η2p = .32, indicating that ratings of 
emotional control increased from pre-treatment to post treatment (Pre-treatment M = 9.21 (3.95); 
Post-treatment M = 11.21 (4.32)). There was a marginally significant main effect for Drug type, 
F (1, 70) = 3.76, p = .056, η2p = .05, indicating that those in the ATX group had somewhat 
higher levels of emotional control overall. However, importantly, there was not a significant 
interaction between Time and Drug type, F (1, 70) = .00, p = 1.00, η2p = .00, indicating that the 













Relations between cognitive and emotional control 
There was no relation between measures of cognitive control and ratings of emotional 
control at the pre-treatment assessment. 
Table 3 
Correlations between Cognitive and Emotional Control at Pre-treatment  
 Commissions   Omissions  Detectability  Mean RT  RT Variability 
Emotional 
Control 
.20 .05 -.17 .00 -.03 
Note. N = 72.  
Does pre-treatment cognitive control predict change in emotional control following treatment 
with MPH and ATX? 
Methylphenidate 
Results of a stepwise regression, presented in Table 4, revealed that of the four cognitive 
control variables entered only detectability accounted for a significant portion of the variance in 
change in emotional control following treatment with MPH, Adjusted R2 = .32, p < .001. The 
direction of the findings was such that poorer detectability at pre-treatment was associated with 
greater improvement in emotional control following treatment with MPH. No other predictors 
















Pre-treatment cognitive control as a predictor of change in emotional control following MPH 
Predictor Adjusted-
R2 
B SE β t p 
Model 1 .32         
 Detectability   .18 .04 .58 4.13 < .001 
 Total R2 .34      
Note. N = 34. 
Atomoxetine 
Results of a stepwise regression, presented in Table 5, revealed that in the first step, pre-
treatment RT variability accounted for a significant 13.1% of the variance in change in emotional 
control following ATX, Adjusted R2 = .10, p < .05. Above and beyond that, omissions accounted 
for an additional 12.6% of the variance in change in emotional control following ATX, Adjusted 
R2 = .20, p < .05. In the final step, commission errors accounted for an additional 12.7% of the 
variance in change in emotional control following ATX, Adjusted R2 = .31, p < .05. The 
direction of the findings was such that greater pre-treatment response consistency predicted 
greater improvement in emotional control following treatment with ATX. In addition, greater 
errors of omission and commission at pre-treatment predicted greater improvement in emotional 











Pre-treatment cognitive control as a predictor of change in emotional control following ATX 
Predictor Adjusted-R2 B SE β t p 
Model 1 .10         
  RT Variability   -.08 .04 -3.62 -2.06 .049 
Model 2 .20      
  RT Variability  -.17 .05  -.76  -3.05 .005 
  Omissions   .05 .03 .53 2.14 .042 
Model 3     .31      
  RT Variability  -.19 .05  -.85  -3.64 .001 
  Omissions   .09 .03 .85 3.17 .004 
  Commissions  .12 .05 .44 2.32 .029 
 Total R2 .38      
Note. N = 30.  
Does change in cognitive control account for changes in emotional control? 
In order to determine the extent to which changes in detectability predicted changes in emotional 
control following treatment, post-treatment T-score values were subtracted from pre-treatment T-
score values for each cognitive control variable. Post-treatment values of cognitive control 











Post-treatment scores for cognitive control  
Variable Total Sample  
(N =72) Mean (SD) 
MPH (N = 39)  
Mean (SD) 
ATX (N = 33)  
Mean (SD) 
Range 
Post-treatment     
Emotional Control 11.2 (4.3) 10.4 (4.1) 12.5 (4.5) 3-20 
Omission Errors 60.02 (17.00) 55.13 (13.91) 65.96 (18.69) 39.90-102 
Mean RT 50.82 (14.23) 47.11 (14.58) 55.32 (12.61) 27.73-91.84 
RT Variability 58.76 (12.69) 55.64 (13.19) 62.55 (11.13) 32.85-83.29 
Detectability 52.95 (9.07) 53.78 (9.45) 51.95 (8.63) 30.8-73.20 
Commission Errors 52.62 (8.75) 54.00 (7.99) 50.95 (9.45) 33.67-70.77 
Note. MPH = Methylphenidate. ATX = Atomoxetine. RT = Response time.  
Methylphenidate 
Results of a stepwise regression shown in Table 7 indicate that in the first step, changes 
in detectability from pre- to post- treatment accounted for 22.7% of the variance in changes in 
emotional control measures following treatment with MPH, Adjusted R2 = .20, p < .01. Above 
and beyond that, changes in mean response time from pre- to post-treatment accounted for 12% 
of the variance in change in emotional control, Adjusted R2 = .30, p < .01. No other changes in 
cognitive control variables predicted changes in emotional control. The direction of findings 
suggests that improved abilities to discriminate between targets and non-targets, and faster mean 












Change in cognitive control as a predictor of change in emotional control following MPH 
Predictor Adjusted-R2 B SE β t p 
Model 1 .20         
 Detectability   .11 .04 .48 2.92 .007 
Model 2 .30      
 Detectability   .11 .03 .51 3.31 .003 
  Mean RT  -.08 .03 -.35 -2.27 .031 
 Total R2 .35      
Note. N = 31.  
Atomoxetine 
Results of a stepwise regression shown in Table 8 indicate that changes in response speed 
consistency from pre- to post-treatment accounted for a significant 33.3% of the variance in 
changes in emotional control following MPH, Adjusted R2 = .33, p < .01. No other changes in 
cognitive control predicted changes in emotional control. The direction of findings suggests that 
improved response speed consistency predicts greater changes in emotional control.  
Table 8 
Change in cognitive control as a predictor of change in emotional control following ATX 
Predictor Adjusted-R2 B SE β t p 
Step 1 .31         
  RT Variability   -.17 .05 -.58 -3.46 .002 
 Total R2 .33      





Medication treatments for ADHD are not only effective for treating behavioral 
symptoms, but they also improve cognitive performance in many individuals (Gualtieri & 
Johnson, 2007). Furthermore, some clinical trials of ADHD medication treatment have shown 
improvements in irritability and emotional lability. Developmental research points to the 
interdependence of cognitive and affective development, but more research is needed to refine 
these connections in ADHD. This is the first study to examine both cognitive and emotional 
control in the context of treatment comparing stimulant and non-stimulant medication. The aims 
of the current study were to 1) examine differential effects of stimulant and non-stimulant 
treatment on changes in emotional control; 2) determine the extent to which pretreatment levels 
of cognitive control predict changes in emotional control following treatment; and 3) examine 
whether greater improvements in cognitive control are associated with greater improvements in 
emotional control following treatment.  
Overall, the data indicate that both stimulant (MPH) and non-stimulant (ATX) treatments 
resulted in significant improvements in emotional control in youth with ADHD, with no 
significant difference between the two classes of medication. Pre-treatment cognitive control 
predicted the extent to which emotional control improved following treatment, with somewhat 
different aspects of pre-treatment cognitive control associated with improvements in emotional 
control with MPH and ATX. Furthermore, improvements in aspects of cognitive control 
accounted for improvements in emotional control. Again, different aspects of cognitive control 




suggest partially distinct mechanisms for change in emotional control for stimulant and non-
stimulant medication treatments.  
Differential effects of drug on changes in emotional control following treatment 
Studies have shown inconsistent findings regarding the usefulness of MPH and ATX in 
treating symptoms of emotion dysregulation (MPH: Biederman et al., 2002; Fernandez et al., 
2014; Manos et al., 2011; ATX: Kratochvil et al., 2007; Reimherr et al., 2005; Sobanski et al., 
2012). The current study is the only one, as far as we know, that examined the comparative 
efficacy of both treatments in a randomized, double-blind, well-controlled clinical trial. Whereas 
we initially hypothesized that treatment with MPH would result in greater improvements in 
emotional control, findings revealed that both MPH and ATX improved emotional control in 
youth with ADHD, and did not differ in regard to the magnitude of change. Our findings are in 
line with previous studies that have shown a positive effect of MPH and ATX on emotion 
dysregulation (MPH: Biederman et al., 2002; Fernandez et al., 2014; Skirrow, McLoughlin, 
Kuntsi, & Asherson, 2009; ATX: Reimherr, et al., 2005; Sobanski et al., 2012). Affective 
control, as an important source of impairment, is another aspect of treatment response to MPH 
and ATX that should be considered.  
The relation between cognitive and emotional control in ADHD 
The present study found that pre-treatment cognitive control emerged as a significant 
predictor of improvements in emotional control following treatment. Specifically, we found that 
several measures of inattention, including pre-treatment detectability, response speed 




emotional control following treatment. This is in line with developmental research which 
indicates an interdependence between cognitive and emotional control, a relation that appears to 
be exemplified in ADHD. There is a large body of literature which has demonstrated that youth 
with ADHD have weaknesses in executive functioning (Willicut et al., 2005), and are also at 
greater risk of experiencing difficulties with anger, mood, and affect regulation (Pliszka et al 
1999). The association between cognitive and affective weaknesses is supported by functional 
imaging studies which reveal that emotion regulation and executive function are both mediated 
by overlapping regions of the prefrontal cortex (Blair, Zelazo, & Greenberg, 2005). Youth with 
ADHD experience a global delay in cortical development (i.e., cortical thickness, cortical surface 
area) with the prefrontal cortex showing the greatest delays (Shaw et al., 2012).  
Current findings are consistent with neurocognitive theories of ADHD which suggest that 
weak cognitive control (e.g., attention, executive functions) accounts not only for weak 
attentional and behavioral regulation, but is also associated with problems in emotion regulation 
(Barkley, 1997; Sagvolden et al., 2005). Understanding the nature of emotion dysregulation in 
this population can lead to the refinement of diagnostic nosology, etiological mechanisms, and 
the development of individualized treatment approaches. 
Mechanisms of Change in Cognitive and Emotional Control in the context of Stimulant and 
Non-Stimulant Treatment 
The current findings support research demonstrating that both stimulant and non-stimulant 
treatments are effective in reducing ADHD symptoms as well as symptoms of behavioral and 
emotional dysregulation. However, the mechanisms underlying specific changes in behavior and 




assess the effects of medication treatment on a neurobiological level, the present study focused 
on neuropsychological constructs of attention and executive functioning to further elucidate 
potential mechanisms that may contribute to changes in behavior.  
The present analyses revealed that different aspects of cognitive control were associated with 
improved emotion regulation for each drug (MPH versus ATX). With regard to pre-treatment 
cognitive control, those individuals with weaker pre-treatment detectability, a measure of 
inattention, were more likely to demonstrate improved emotional control following treatment 
with MPH. Furthermore, children who had improved detectability and faster response time 
following treatment with MPH were most likely to show improvement in emotional control. 
Dozens of studies assessing cognitive effects of MPH in ADHD samples have found faster RT 
following treatment on various tasks of attention and executive functioning (for a complete list, 
see Coghill et al., 2014 Table 3). Current findings may suggest that increased detectability drives 
faster response times during Go/No-go tasks through increased efficiency of responding. 
Improved abilities to distinguish between targets and non-targets has been hypothesized to 
increase the likelihood of recruiting cognitive control processes required to respond 
appropriately to a provoking situation (Nigg & Casey, 2005; Castellanos, Sonuga-Barke, 
Milham, & Tannock, 2006).  
A different set of measures of inattention emerged as pre-treatment predictors of 
improvement in emotional control following ATX. Specifically, improvement in emotional 
control following ATX treatment was associated with response speed consistency, and rates of 
commission and omission errors. Notably, individuals with more consistent response time at pre-




with MPH, individuals with weaker attention and inhibitory abilities (greater omission and 
commission errors) at pre-treatment were more likely to demonstrate improvement in emotional 
control. When looking at changes in cognitive control, only response time variability, a measure 
of sustained attention/vigilance, emerged as a significant predictor of improvement in emotional 
control. Overall, current findings support the likelihood that some degree of improvement in 
attention regulation as quantified by neuropsychological measures positively impacts the 
strengthening of affective self-regulatory abilities over time.  
Neurodevelopmental Perspectives on the relation between Cognitive and Emotional 
Control  
Etiological models emphasize heterogeneity in the mechanisms responsible for ADHD. 
Theories have attempted to identify neural substrates associated with distinct symptom 
dimensions. For example, some theories propose that deficits in pre-frontally mediated cognitive 
functions (sustained attention, response inhibition, working memory) are associated with 
inattentive behaviors (Barkley, 1997; Baddeley, 1992). This reflects the contribution of deficits 
in “top-down” executive self-regulatory processes. Top-down circuits (i.e., frontostriatal, 
frontocerebellar) are learning systems that work together to monitor the environment and alter 
attention and behavior. They provide a means to adjust behavior via projections from areas in the 
PFC to subcortical structures (e.g., striatum) and cerebellar cortices (Nigg & Casey, 2005). Other 
theories of ADHD propose that dysregulated delay tolerance and difficulty waiting for rewards 
are associated with hyperactive-impulsive behaviors (Nigg, Goldsmith, & Sachek, 2004; 
Sonuga-Barke, 2005). This reflects the “bottom-up” difficulties with the regulation of behavioral 




project information from the limbic system (e.g., amygdala, nucleus accumbens) to the 
orbitofrontal and ventromedial prefrontal cortex (Bechara, 2004; Beer, John, Scabini, & Knight, 
2006) and underlie affective responses. These models present an over-simplified perspective and 
fail to account for the continuous, dynamic, and adaptive processes that underlie the 
development of self-regulation. The current study seeks to elucidate the relation between 
cognitive and affective aspects of self- regulation to advance current theoretical models of 
ADHD that better reflect accompanying difficulties with emotions and behavior.  
Overall, research indicates that MPH and ATX show shared as well as distinct drug-specific 
effects on frontal activation, ultimately increasing cortical top-down control albeit through 
slightly different mechanisms (Bush et al., 2008; Bush et al., 2013; Schulz et al., 2012). This is 
consistent with the current study’s findings that treatment with MPH and ATX lead to 
improvements in different aspects of attention. Neurodevelopmental models might explain how 
improvements in attention following psychopharmacological treatment contribute to 
improvements in emotional control. Cognitive and affective regulatory systems exert differential 
influences on each other and on behavior at different developmental periods. As cognitive 
control matures with age, it plays a greater role in modulating emotional control (Murray & 
Kochanska, 2002; Perlman & Pelphery, 2010; Posner & Rothbart, 2000). For example, 
neuroimaging studies have shown an inverse correlation between activity in the prefrontal cortex 
and activity in limbic regions (amygdala) which has been interpreted as reflecting the top-down 
modulation of bottom up emotional processes (Hare et al., 2008). Further, high effortful control 
is consistently related to stronger attention and executive functioning as well as lower negative 
affect (Eisenberg et al., 2009, 2010; Hill et al., 2006; Rothbart & Rueda, 2005). A recent study 




emotional dysregulation (i.e., anger/frustration) and later ADHD symptomatology in a 
longitudinal sample found that executive control had a partially mediating effect (Rabinovitz, 
O’Neill, Rajendran, & Halperin, 2016). The mediating effect of executive functioning (at six 
years) on the relation between early anger/frustration (at three to four years old) and later ADHD 
severity (at seven years old) suggests that poor bottom-up regulation reflects an early risk for 
later behavioral difficulties through their impact on top-down control. Thus, the developmental 
perspective emphasizes the interdependence of cognitive and affective regulatory processes over 
time, such that as prefrontal circuitry matures and strengthens cognitive control with age, it 
modulates bottom-up affective regulation. This is in line with the current study’s findings that 
improvements in top-down cognitive control following treatment significantly contribute to 
improvements in bottom-up emotional control.  
Current findings suggest that treatment with MPH and ATX enhances top-down regulatory 
control by targeting attentional processes such as response speed, vigilance, and detectability. 
Strengthened top-down control following medication treatment may facilitate the functioning of 
brain areas and circuitry in ADHD to a level that more closely resembles that which is present in 
typical development (Clerkin et al., 2013; Shaw, Gogtay, & Rapoport, 2010). Thus, current 
findings suggest that medication effects mimic developmental processes. As is the case during 
typical development, the enhancement of top-down control that occurs with maturation of pre-
frontal limbic connections enables the modulation of bottom-up regulatory processes which 






Ecological Validity of our Findings: Hot and Cool Executive Functions 
The next step in refining our understanding of the relations between cognitive and emotional 
control raises important challenges to the field of neuropsychology. Namely, there is debate 
regarding the extent to which improvements on neuropsychological task performance is 
generalizable to real-world situations. For example, a recent study examining the effects of 
intensive cognitive working memory training found improvements in trained working memory 
outcomes that closely resembled the skills practiced (e.g., digit recall, visuospatial memory), but 
findings did not generalize to other domains of functioning (e.g., ADHD symptoms, academic 
achievement; Chacko et al., 2014). The current study examined cognitive functioning during an 
emotionally neutral task (Conners’ CPT). Nevertheless, parents rated affective regulation based 
on daily functioning in real-world situations which inherently enhances the ecological validity of 
the current study’s findings.  
The overlap and distinction between the processing of neutral versus emotion-laden 
information has led to the formulation of ‘cool’ and ‘hot’ executive functions, respectively 
(Zelazo & Carlson, 2012). Cool executive functions are characterized by inhibitory control, 
flexibility, working memory, and monitoring that occurs in emotionally neutral conditions. In 
contrast, hot executive functions are those goal-directed cognitive processes elicited in 
emotionally-laden contexts. For example, the ability to delay gratification, to weigh 
consequences, and to process rewards. Hot executive functions lay at the intersection between 
cognition and emotion which is important for adaptive functioning. It is likely that “hot” aspects 
of cognitive control may show more robust prediction to changes in affective control, and may 




aspects of cognitive control in neutral contexts and daily affective functioning. That said, the 
examination of “hot” executive control processes may provide a better understanding of the 
neural mechanisms that underlie emotional dyscontrol. Future studies should comparatively 
assess cognitive control in the context of tasks that are neutral (i.e., Stroop-like tasks, card-
sorting tasks) or emotionally salient (I.e., Iowa Gambling Task). This research will likely make 
stronger contributions to our understanding of the dynamic relations between complex cognitive 
and affective processes that underlie behavior.  
Clinical implications 
 Research has long demonstrated that medication treatments for ADHD lead to 
improvements in attentional and behavioral symptoms. The current findings suggest that MPH 
and ATX also contribute to improvements in emotional control in youth with ADHD, albeit via 
partially distinct mechanisms. While cognitive and affective control are distinct constructs, they 
are not orthogonal. More research is necessary to further elucidate the complex relations between 
cognitive and emotional control in children with ADHD.  
The management of emotion dysregulation within ADHD is therapeutically challenging. 
However, the current study is among others that demonstrate that MPH and ATX improve both 
core symptoms of ADHD as well as emotion dysregulation. Therefore, treatment with these 
medications may be considered a viable first line of treatment. Further, cognitive and behavioral 
treatments have been found to be effective for the treatment of internalizing and externalizing 
symptoms which often accompany ADHD (Jensen, Hinshaw, Kraemer, Lenora, Newcorn, 




psychotherapy targeting emotion dysregulation is also efficacious (Mongia & Hechtman, 2012; 
Sonuga-Barke, Brandeis, Cortese, Daley, Ferrin, Holtmann, et al., 2013). Current findings that 
stronger cognitive control contributes to stronger affective control suggest that cognitive 
treatments targeting “cool” and “hot” executive functions may promote further development of 
affective control. Therefore, treatments targeting cognitive control and emotion regulation may 
further attenuate emotion dysregulation in individuals with ADHD. 
Research into understanding the development of cognitive, emotional, and behavioral 
processes in ADHD and how they contribute to self-regulatory abilities holds promise for 
building novel treatment approaches that target underlying pathophysiological mechanisms. 
These preliminary findings raise the possibility that cognitive control can serve as a biomarker 
for who might have the most robust response to treatment. Future studies should continue 
exploring whether cognitive control measures may be used for predicting changes in emotional 
control. 
Strengths and Limitations  
There are several notable strengths to the current study, including a well-characterized 
clinically-referred sample, a double-blind randomized control design and parallel-group analysis. 
Validity is further strengthened by the 2-week washout period prior to randomization for those 
participants who were not medication-naïve, thus reducing/eliminating confounding medication 
effects. In addition, participants received chronic rather than single doses of each medication, 
with end of treatment assessments occurring at optimized clinical efficacy (based on individual 




effects, ATX could require as long as six to eight weeks of chronic administration in order to 
demonstrate behavioral effects (Montoya et al., 2009).  
An additional strength of the current study was the use of subjective ratings and objective 
measures of emotional and cognitive control, respectively. This allowed for a measure of 
cognitive control that was not confounded by having the same observer rate multiple behavioral 
targets (e.g., correlational observer bias, Dyad-specific variance).  
The lack of a placebo control group presents a potential confound when interpreting analyses 
of differential improvement in emotional control following treatment. Namely, it precludes the 
ability to see the non-specific effects of time. It is conceivable that the significant improvements 
for both MPH and ATX are the result of a time effect that is not related to the medication. In 
addition, lack of a placebo group precludes our ability to control for potential effects of parental 
expectations of treatment.  
When interpreting results of the current study it is difficult to parse out whether improved 
behavioral ratings of emotion dysregulation are secondary to ADHD symptom improvement, as 
opposed to improving as a direct effect of medication. While co-varying for ADHD symptom 
improvement was considered, it was ultimately decided that doing so may have reduced 
variability needed in order to examine the relation between cognitive and affective control. 
Furthermore, ADHD symptoms and emotional dyscontrol are very highly correlated, and may 
have introduced problems with collinearity which would have made it difficult to assess the 
effect of cognitive control on emotional control. Therefore, the current methods are preferable 




Our measures of cognitive control were derived from the CPT, which is among the most 
sensitive measures for differentiating ADHD (Berwid et al., 2005; Doehnert, Brandeis, Imhof, 
Drechsler, & Steinhausen, 2010). However, a limitation of the current study is that we relied on a 
single test which generated multiple measures of cognitive control. Similar to most other Go/No-
Go tasks, the Conners’ CPT focuses primarily on sustained attention and response inhibition. 
While it generates various performance indices (e.g., omission errors, commission errors, mean 
hit reaction time), what each parameter actually assesses is largely based on clinical assumptions 
and the face validity of each measure. It would be better to use measures that truly isolate 
individual cognitive functions, although this is theoretically nearly impossible. A broader set of 
measures examining other areas of executive functioning (e.g., working memory, planning, set 
shifting, etc.) may have provided a different set of relations between cognitive and affective 
control. Furthermore, one must consider that the effects of medications are broad, and they don’t 
necessarily influence a specific circuit. While MPH and ATX are different, they influence many 
of the same neurotransmitter systems in the PFC, either directly or indirectly. Therefore, it is not 
surprising that cognitive control predictors did not differ in a more substantial way. 
 The current sample size did not permit the comparison of the relation between cognitive 
and emotional control between different age groups. Evidence from developmental literature 
demonstrates the strong influence of age on the maturation of cognitive and affective abilities 
(Bunge & Wright, 2007; Rubia, 2013), as well as the non-linear development of brain areas and 
circuitry important to these processes, particularly in an ADHD sample (Posner & Rothbart, 
2000; Shaw et al., 2012). Nevertheless, an individual’s T-scores on the CPT are based on a large 
normative sample (N = 1,920) matched by age and gender. Therefore, the cognitive control 




matched control group would enhance the understanding of developmental differences in the 
relation between cognitive and emotional control comparing individuals off and on medication. 
Furthermore, a within-subject design would allow for a more direct comparison of the cognitive 
and emotional correlates under both medication conditions. Of note, the parent study did include 
a placebo control during the washout period between crossover trials. Therefore, comparisons of 
placebo versus drug and within-subject analysis across drugs are an area of future study.  
This research is a first step towards understanding the effects of current efficacious 
psychopharmacological treatments on emotional control, which is a necessary step towards being 
able to refine and improve upon treatments for ADHD. Overall, the current study data suggest 
that stimulant and non-stimulant medications do have an impact on emotional control. Further, 
changes in emotional control appear to be at least in part predicted by pre-treatment levels of 
cognitive control, or moderated by changes in cognitive control. Importantly, changes in 
cognitive control do not fully account for changes in emotional control. Future studies should 






The two studies that formed this dissertation were undertaken to better understand the 
nature of irritability and broader emotion dyscontrol in youth with ADHD. Specifically, using a 
prospective longitudinal design, we examined the developmental stability of irritability from 
childhood through adolescence/early adulthood, and the degree to which its presence and 
variability in childhood predicts adolescent outcomes. In addition, we explored the degree to 
which emotion dysregulation improved following treatment with stimulant and non-stimulant 
medications, and the relations between cognitive and emotional control in the context of 
psychopharmacological treatment response. Answers to these questions could inform treatment 
research and lead to the development of targeted interventions that could attenuate poor 
outcomes associated with irritability in an ADHD population.  
 The hypothesis of Study 1 was that irritability would be stable over time and would 
predict later internalizing outcomes. Although irritability did demonstrate moderate stability over 
time, with less stability in individuals with low SES, childhood irritability did not predict 
internalizing outcomes in our sample of youth with ADHD. Nevertheless, early irritability 
predicted later externalizing problems including anger and aggression, as well as cigarette use. 
Neither SES nor history of maltreatment moderated the relation between early irritability and 
these outcomes. Our findings indicate that irritability is maladaptive in an ADHD population, 
and has negative consequences for longitudinal outcomes, perhaps by increasing risk for later 
aggression and substance use. Given concurrent impairments and negative longitudinal outcomes 





 The hypotheses of Study 2 were that 1) MPH, relative to ATX, would result in a greater 
diminution of irritability following treatment, and 2) improvements in emotional control 
following stimulant and non-stimulant medication treatment are supported, at least in part, by 
improvements in cognitive control. Both classes of medication demonstrated comparable 
improvements in emotional control. More specifically, pre-treatment levels of cognitive control 
were associated with improvements in emotional control. In addition, improved cognitive control 
following medication treatment contributed to improvements in emotional control.  
The amalgamation of the findings raises the possibility that unlike the irritability that was 
examined in other (primarily community-based) samples (Leibenluft et al., 2006; Stringaris et 
al., 2009), the irritable symptoms associated with ADHD may be less related to mood disorders. 
Instead, irritability in ADHD may be more related to core disruptions in regulatory processes that 
underlie the disorder. This is consistent with Barkley’s (1997, 2006) model in which ADHD is a 
disorder of deficient executive functioning, with core deficits in emotional inhibition and 
emotional self-regulation. Several studies, including the present one, have demonstrated the 
relation between executive functioning and emotion regulation in children and adolescents with 
ADHD, suggesting that emotion dysregulation in ADHD is associated with the same core 
deficits in attention and behavioral control (Hoeksma, Oosterlaan, & Schipper, 2004; 
Liebermann, Giesbrecht, & Muller, 2007; Mahone & Hoffman, 2007; Walcott & Landau, 2004). 
The relation between executive and affective impairments persist through adulthood (Barkley, 
Murphy, & Fischer, 2008), and adults with ADHD and mood lability have also shown affective 
improvements following stimulant and non-stimulant treatment (Reimherr et al., 2007). Taken 
together, it is likely that inattentive, hyperactive/impulsive, and emotional dyscontrol symptoms 




conclude that emotion dysregulation is a core component of ADHD based on the current findings 
alone. Further research is needed to continue refining the conceptualization of emotion 
dysregulation in ADHD. For example, is emotion dysregulation an integral component of ADHD 
(as proposed by Barkley), is ADHD + emotion dysregulation a distinct subtype, or are ADHD 
and emotion dysregulation distinct, yet highly correlated dimensions resulting from multiple but 
modestly overlapping pathways to ADHD?  
In the interim, the results of the current dissertation provide a rationale for considering 
interventions that target cognitive control in the treatment of individuals with ADHD and 
emotion dysregulation. For example, child-directed cognitive behavioral therapy (CBT) teaches 
skills for coping with frustration and other aspects of emotion dysregulation (Dodge, 2003). 
Common techniques include learning strategies for recognizing and regulating anger expression, 
and modeling and rehearsing more appropriate reactions. Anger control training (ACT; Lochman 
et al., 2003), problem-solving skills training (PSST; Dodge, 2003), and social skills training 
(SST) are different approaches to cognitive behavioral therapy. In addition, executive function 
training targets weak cognitive skills including inhibitory control (which is helpful for self-
regulation), cognitive flexibility, and problem-solving abilities. Given current findings that 
improvements in “top-down” cognitive control contribute to improved emotion regulation, 
executive function training can be considered an effective adjunctive treatment for children with 
ADHD and emotion dyscontrol.  
The current dissertation has several strengths including the racially and ethnically 
diverse, well-characterized, clinical samples with ADHD who were diagnosed using rigorous 




pre-existing data from two different studies. For example, since different rating scales were 
utilized in each study, definitions of irritability and emotion dysregulation differed across the two 
studies. Nevertheless, irritability is one aspect of broader problems with emotion regulation. It is 
important that future studies of emotion dysregulation clearly operationalize the construct (e.g., 
emotional lability, affect lability, emotional dysregulation, irritability, tantrums, emotional 
outbursts, unhappy). The current dissertation was also limited to relying on one measure of 
“cold” cognitive control (Conners’ CPT), and one measure of emotional control derived from a 
larger parent rating scale (SSRS). Future studies would benefit from using more measures of 
cognitive control that isolate distinct cognitive functions (i.e., inhibition, set-shifting, working 
memory) under neutral and emotionally salient conditions, and using rating scales that explore 
executive functioning and emotion dysregulation in greater depth (for example, the Behavior 
Rating Inventory of Executive Function). 
  The current findings contribute to research on irritability, and indicate that irritability 
manifests differently in ADHD versus community samples. Whereas irritability is related to 
affective distress (mood disorders) in community based samples, it is related to externalizing 
problems in ADHD which is consistent with the conceptualization that irritability reflects 
deficient emotional self-regulation. The fact that medications that improve inattention and 
hyperactivity/impulsivity in youth with ADHD also reduce emotional dysregulation in these 
youth raises the possibility of a common biological basis for these three symptom domains that is 
unique to ADHD. Nevertheless, current findings also demonstrate that stimulant and non-
stimulant treatments for ADHD contribute to improvements in emotional control through both 
shared and distinct mechanisms. This research is a first step towards being able to refine and 




studies that examine affective symptoms throughout development and identify other factors 
linked to emotional control in individuals with ADHD. Research should encompass a broader set 
of neuropsychological measures of executive functioning in order to further elucidate the relation 
between cognitive and emotional regulation. Up until this point, most neuroimaging studies of 
treatment effects have focused on frontostriatal and frontocerebellar networks; however, 
neuroimaging which also investigates prefrontal limbic circuits in the context of treatment will 
likely shed light on mechanisms underlying changes in emotional control.  
Overall, we found that irritability in school age children with ADHD is highly impairing, 
stable, and portends future externalizing problems. Stimulant and non-stimulant 
psychopharmacological treatments are effective for attenuating ADHD symptoms as well as 
emotion dysregulation, at least acutely. Findings suggest that improvements in emotional control 






Socioeconomic Status.  
Irritability. 
Table A1  
Socioeconomic Status (SES) as a Potential Moderator of the relation between Childhood 
Irritability and Adolescent Depression  
Predictor  ΔR2 B SE Β 
Step 1 .01       
  Childhood Irritability   -.60 1.82 -.04 
  SES   .03 .07 .06 
Step 2 .03       
  Childhood Irritability   -1.01 1.83 -.07 
  SES   .03 .07 .05 
  Childhood Irritability X SES  .13 .09 .17 
Total R2 .03    




Socioeconomic Status (SES) as a Potential Moderator of the relation between Childhood 
Defiance and Adolescent Depression  
Predictor ΔR2 B         SE     β 
Step 1 .01       
  Childhood Defiance   -.60 2.26 -.03 
  SES   .03 .07 .05 
Step 2 .01       
  Childhood Defiance   -.28 2.31 -.02 
  SES   .02 .07 .04 
  Childhood Defiance X SES  -.08 .11 -.08 
Total R2 . 01    




Socioeconomic Status.  
Irritability. 
Table A3  
Socioeconomic Status (SES) as a Potential Moderator of the Relation between Childhood 
Irritability and Adolescent State Anxiety  
Predictor  ΔR2 B SE β 
Step 1 .02       
  Childhood Irritability   -.85 1.83 -.05 
  SES   -.08 .07 -.14 
Step 2 .03       
  Childhood Irritability   -1.27 1.84 -.08 
  SES   -.08 .07 -.15 
  Childhood Irritability X SES  .14 .09 .18 
Total R2 .05    
Note. N = 75.  
Table A4  
Socioeconomic Status (SES) as a Potential Moderator of the Relation between Childhood 
Irritability and Adolescent Trait Anxiety  
Predictor  ΔR2 B SE β 
Step 1 .01       
  Childhood Irritability   -1.23 1.88 -.08 
  SES   .01 .07 .02 
Step 2 .04       
  Childhood Irritability   -1.72 1.87 -.11 
  SES   .01 .07 .01 
  Childhood Irritability X SES  .17 .09 .21 
Total R2 .05    








Socioeconomic Status (SES) as a Potential Moderator of the Relation between Childhood 
Defiance and Adolescent State Anxiety  
Predictor  ΔR2 B SE β 
Step 1 .02       
  Childhood Defiance   -.25 2.30 -.02 
  SES   -.08 .07 -.14 
Step 2 .00       
  Childhood Defiance   -.25 2.36 -.01 
  SES   -.08 .07 -.14 
  Childhood Defiance X SES  -.04 .12 -.04 
Total R2 .02    
Note. N = 75.  
Table A6 
Socioeconomic Status (SES) as a Potential Moderator of the relation between Childhood 
Defiance and Adolescent Trait Anxiety  
Predictor  ΔR2 B SE β 
Step 1 .00       
  Childhood Defiance   -1.14 2.35 -.06 
  SES   .01 .07 .01 
Step 2 .00       
  Childhood Defiance   -1.25 2.41 -.06 
  SES   .01 .07 .02 
  Childhood Defiance X SES  .03 .12 .03 
Total R2 .01    
















Maltreatment as a Potential Moderator of the relation between Childhood Irritability and 
Adolescent State Anxiety 
Predictor  ΔR2 B SE β 
Step 1 .00       
  Childhood Irritability   -.70 1.99 -.04 
  Maltreatment   .65 2.81 -.03 
Step 2 .10*       
  Childhood Irritability   6.41 3.22 .41† 
  Maltreatment   .45 2.71 -.02 
  Childhood Irritability X Maltreatment  -10.87 3.98 -.55* 
Total R2 .11††    
Note. N = 68. † p = .051, †† p = .064* p < .01.  
In order to understand the nature of the Childhood Irritability X Maltreatment interaction 
as a predictor of adolescent ratings of state anxiety, the interaction was plotted and the simple 
slopes examined. Figure A1 illustrates the relation between childhood irritability and adolescent 
state anxiety for individuals with and without a history of childhood maltreatment. As depicted 
in the figure, childhood irritability positively predicted adolescent state anxiety for those who did 
not have a history of maltreatment in childhood (t (64) = 1.98, p = .052); however, this relation 
was only marginally significant. For those who did have a history of maltreatment in childhood, 
childhood irritability had a non-significant inverse relation with ratings of adolescent state 






































Maltreatment as a Potential Moderator of the relation between Childhood Defiance and 
Adolescent State Anxiety 
Predictor  ΔR2 B SE β 
Step 1 .00       
  Childhood Defiance   -.34 2.47 -.02 
  Maltreatment   .56 2.82 .03 
Step 2 .05       
  Childhood Defiance   3.76 3.34 .19 
  Maltreatment   .27 2.78 .01 
  Childhood Defiance X Maltreatment  -8.68 4.86 -.30† 
Total R2 .05    
Note. N = 68, † p = .079.  
The results of a separate multiple regression analysis, presented in Table A9, indicated 
that neither childhood defiance nor a history of maltreatment emerged as significant predictors of 




as significant predictor of ratings of trait anxiety in adolescence. Importantly, the overall model 
was not significant; therefore the following should be interpreted with caution.  
In order to understand the nature of the Childhood Defiance X Maltreatment interaction 
as a predictor of adolescent ratings of trait anxiety, the interaction was plotted and the simple 
slopes examined. Figure A2 illustrates the relation between childhood defiance and adolescent 
trait anxiety for individuals with and without a history of childhood maltreatment. As depicted in 
the figure, childhood defiance positively predicted adolescent ratings of trait anxiety for those 
who did not have a history of maltreatment in childhood; however, this relation was not 
significant (t (63) = .70, p = .486). For those who endorsed a positive history of maltreatment in 
childhood, childhood defiance had a significant inverse relation with ratings of adolescent trait 
anxiety (t (63) = -2.15, p = .035).  
Table A9 
Maltreatment as a Potential Moderator of the relation between Childhood Defiance and 
Adolescent Trait Anxiety 
Predictor  ΔR2 B SE β 
Step 1 .05       
  Childhood Defiance   2.37 2.41 -.12 
  Maltreatment   4.58 2.76 .20 
Step 2 .06*       
  Childhood Defiance   2.34 3.24 .12 
  Maltreatment   4.24 2.70 .19 
  Childhood Defiance X Maltreatment  -9.96 4.71 -.35* 
Total R2 .11†    















Socioeconomic Status.  
Irritability. 
Table B1 
Socioeconomic Status (SES) as a Moderator of the association between Childhood Irritability 
and Adolescent Verbal Aggression 
Predictor ΔR2 B SE β 
Step 1 .02       
  Childhood Irritability   .90 .70 .15 
  SES   -.002 .03 -.01 
Step 2 .00       
  Childhood Irritability   .86 .71 .15 
  SES   -.002 .03 -.01 




.01 .04 .05 
 
Note. N = 73.  
 
Table B2 
Socioeconomic Status (SES) as a Moderator of the association between Childhood Irritability 
and Adolescent Hostility 
Predictor ΔR2 B SE β 
Step 1 .02       
  Childhood Irritability   -.66 1.39 -.06 
  SES   -.06 .05 -.14 
Step 2 .000       
  Childhood Irritability   -.67 1.41 -.06 
  SES   -.06 .05 -.14 




-.003 .07 -.01 
 









Socioeconomic Status (SES) as a Moderator of the association between Childhood Defiance and 
Adolescent Anger 
Predictor ΔR2 B SE β 
Step 1 .05       
  Childhood Defiance   2.06 1.44 .17 
  SES   -.04 .04 -.11 
Step 2 .01       
  Childhood Defiance   1.88 1.48 .16 
  SES   -.04 .04 -.10 




.04 .07 .07 
 
Note. N = 73.  
 
Table B4 
Socioeconomic Status (SES) as a Moderator of the association between Childhood Defiance and 
Adolescent Verbal Aggression 
Predictor ΔR2 B SE β 
Step 1 .003       
  Childhood Defiance   .40 .88 .06 
  SES   -.002 .03 -.01 
Step 2 .001       
  Childhood Defiance   .36 .90 .05 
  SES   -.001 .03 -.003 




.01 .04 .03 
 
















Socioeconomic Status (SES) as a Moderator of the association between Childhood Defiance and 
Adolescent Hostility 
Predictor ΔR2 B SE β 
Step 1 .03       
  Childhood Defiance   -1.52 1.71 -.11 
  SES   -.07 .05 .16 
Step 2 .001       
  Childhood Defiance   -1.61 1.76 -.11 
  SES   -.07 .05 -.16 




.02 .09 .03 
 
Note. N = 73.  
 
Childhood Maltreatment.  
 
Table B6 
t-test Results Comparing Ratings of Physical Aggression in Adolescence and the Presence of a 
History of Maltreatment  
Maltreatment 
History 
n Mean SD t df p 
Yes 45  27.80  7.55  -1.68 66 .10 
No 23  23.96  9.56     
Note. N = 68. SD = Standard Deviation 
Table B7 
t-test Results Comparing Ratings of Verbal Aggression in Adolescence and the Presence of a 
History of Maltreatment  
Maltreatment 
History 
n Mean SD t df p 
Yes 45  17.24  4.12  -.32 66 .75 
No 23  16.91  3.87     
















n Mean SD t df p 
Yes 45  20.69  5.92  -1.44 66 .16 
No 23  17.96  8.03     
Note. N = 68. SD = Standard Deviation 
Table B9 




n Mean SD t df p 
Yes 45  21.80  7.50  -.54 66 .59 
No 23  20.70  8.76     
Note. N = 68. SD = Standard Deviation 
Table B10 
Maltreatment as a Moderator of the association between Childhood Irritability and Adolescent 
Verbal Aggression 
Predictor ΔR2 B SE β 
Step 1 .02       
  Childhood Irritability   .85 .73 .14 
  Maltreatment   .14 1.04 .02 
Step 2 -.002       
  Childhood Irritability   .52 1.26 .09 
  Maltreatment   .19 1.06 .02 




.51 1.56 .07 
 















Maltreatment as a Moderator of the association between Childhood Irritability and Adolescent 
Hostility 
Predictor ΔR2 B SE β 
Step 1 .01       
   Time       
  Childhood Irritability   -.81 1.45 -.07 
  Maltreatment   1.28 2.07 .08 
Step 2 .03       
  Childhood Irritability   1.91 2.47 .17 
  Maltreatment   .87 2.08 .05 




-4.13 3.04 -.29 
 
Note. N = 68.  
 
Table B12 
Maltreatment as a Moderator of the association between Childhood Defiance and Adolescent 
Anger 
Predictor ΔR2 B SE β 
Step 1 .08       
  Childhood Defiance   2.51 1.50 .20 
  Maltreatment   2.24 1.72 .16 
Step 2 .03       
  Childhood Defiance   4.45 2.05 .36* 
  Maltreatment   2.10 1.71 .15 




-4.11 2.99 -.23 
 

















Maltreatment as a Moderator of the association between Childhood Defiance and Adolescent 
Verbal Aggression 
Predictor ΔR2 B SE β 
Step 1 .01       
  Childhood Defiance   .49 .92 .07 
  Maltreatment   .24 1.06 .03 
Step 2 .01       
  Childhood Defiance   1.09 1.28 .15 
  Maltreatment   .19 1.06 .02 




-1.29 1.86 -.12 
 
Note. N = 68.  
 
Table B14 
Maltreatment as a Moderator of the association between Childhood Defiance and Adolescent 
Hostility 
Predictor ΔR2 B SE β 
Step 1 .01       
  Childhood Defiance   -1.45 2.49 .04 
  Maltreatment   1.39 2.07 .07 
Step 2 .02       
  Childhood Defiance   .56 2.49 .04 
  Maltreatment   1.24 2.07 .08 




-4.24 3.62 -.20 
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